image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
b1fa38f5a7d44f2767042c0f3c36e8a2843c5f3a7678e91b64f4e14417aa8d1c.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="9">Residual level, mg/kg</td><td><i>μ</i>g/product</td></tr><tr><td>2,6-TDI</td><td>IPDI-1</td><td>IPDI-2</td><td>2,4-TDI</td><td>PI</td><td>CHI</td><td>4,4′-MDI</td><td>H12MDI</td><td>Total</td><td>Total</td></tr><tr><td>Glove 1</td><td>0.013</td><td>ND</td... | <table><tr><td rowspan="2">Sample</td></tr><tr></tr><tr><td>Glove 1</td></tr><tr><td>Glove 2</td></tr><tr><td>Pastry bag</td></tr><tr><td></td></tr><tr><td>Glove 1</td></tr><tr><td>Glove 2</td></tr><tr><td>Pastry bag</td></tr></table> | <table><tr><td colspan="9">Residual level, mg/kg</td><td>μg/product</td></tr><tr><td>2,6-TDI</td><td>IPDI-1</td><td>IPDI-2</td><td>2,4-TDI</td><td>PI</td><td>CHI</td><td>4,4′-MDI</td><td>H12MDI</td><td>Total</td><td>Total</td></tr><tr><td>0.013</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>0.064</td><t... |
af45c88a9138aeb934bdf7aad1da51c7a87edb8b3eea736fa000e1bf628fad15.png | complex | <table><tr><td># layers</td><td># hidden units</td><td>Sens.</td><td>Spec.</td><td>F1</td><td>Macro Ave.</td><td>Mic. Ave.</td></tr><tr><td>1</td><td>512</td><td>0.823</td><td>0.904</td><td>0.724</td><td>0.864</td><td>0.89</td></tr><tr><td>1</td><td>1024</td><td>0.83</td><td>0.911</td><td>0.738</td><td>0.87</td><td>0.8... | <table><tr><td># layers</td><td># hidden units</td><td>Sens.</td><td>Spec.</td><td>F1</td><td>Macro Ave.</td></tr><tr><td>1</td><td>512</td><td>0.823</td><td>0.904</td><td>0.724</td><td>0.864</td></tr><tr><td>1</td><td>1024</td><td>0.83</td><td>0.911</td><td>0.738</td><td>0.87</td></tr><tr><td>1</td><td>1536</td><td>0.... | <table><tr><td>Mic. Ave.</td></tr><tr><td>0.89</td></tr><tr><td>0.896</td></tr><tr><td>0.895</td></tr><tr><td>0.896</td></tr><tr><td>0.896</td></tr><tr><td>0.894</td></tr><tr><td>0.896</td></tr><tr><td>0.894</td></tr><tr><td>0.893</td></tr><tr><td>0.892</td></tr><tr><td>0.892</td></tr><tr><td>0.893</td></tr><tr><td>0.8... |
e62c81974a96dfdcacb83886a1a56e7fbaab91f7ffa04f01d0a257aa1c9c0704.png | complex | <table><tr><td>Number of conditions</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td>No chronic health condition</td><td colspan="3">REFERENCE</td></tr><tr><td>Arthritis only</td><td>1.64</td><td>1.13 – 2.38</td><td>0.0099</td></tr><tr><td>Arthritis and one other condition</td><td>2.95</td><td>1.82 R... | <table><tr><td>Number of conditions</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td>No chronic health cond</td><td colspan="3">REFER</td></tr></table> | <table><tr><td>ition</td><td colspan="3">ENCE</td></tr><tr><td>Arthritis only</td><td>1.64</td><td>1.13 – 2.38</td><td>0.0099</td></tr><tr><td>Arthritis and one other condition</td><td>2.95</td><td>1.82 – 4.80</td><td><.0001</td></tr><tr><td>Arthritis and two other conditions</td><td>2.80</td><td>1.50 – 5.26</td><td>0.... |
d3159ec3602382f0f369fffd2a3c8c09312254c673d9a252d78477fd3c5ae82f.png | complex | <table><tr><td></td><td colspan="4">Risky sexual practices</td></tr><tr><td></td><td>Bivariate model</td><td>Model-I</td><td>Model-II</td><td>Final model</td></tr><tr><td>Variables/characteristics</td><td>Crude IRR (95% CI)</td><td>Adj. IRR (95% CI)</td><td>Adj. IRR (95% CI)</td><td>Adj. IRR (95% CI)</td></tr><tr><td>P... | <table><tr><td></td><td colspan="4">Risky sexual practices</td></tr><tr><td></td><td>Bivariate model</td><td>Model-I</td><td>Model-II</td><td>Final model</td></tr><tr><td>Variables/characteristics</td><td>Crude IRR (95% CI)</td><td>Adj. IRR (95% CI)</td><td>Adj. IRR (95% CI)</td><td>Adj. IRR (95% CI)</td></tr><tr><td>P... | <table><tr><td>Data-not obtained</td><td>0.95 (0.702, 1.283)</td><td></td><td>0.89 (0.657, 1.228)</td><td>0.89 (0.649, 1.214)</td></tr><tr><td>Expendable pocket money per month</td><td></td><td></td><td></td><td></td></tr><tr><td>≤100 ETB</td><td>1 (Ref)</td><td></td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td>101–200... |
6f1f6ea491ac7a1d8e014046765eca5bd2c7612ed5350eefefc7b8f3bf5d969b.png | simple | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Highest heart rate</td><td>119 ± 25 beats/minute</td></tr><tr><td>Highest respiratory rate</td><td>31.7 ± 8.9 breaths/minute</td></tr><tr><td>Mean APACHE II score</td><td>19.8 ± 7.8</td></tr><tr><td>Mean SAPS II score</td><td>40.2 ± 16.1</td></... | <table><tr><td>Parameter</td></tr><tr><td>Highest heart rate</td></tr><tr><td>Highest respiratory rate</td></tr><tr><td>Mean APACHE II score</td></tr><tr><td>Mean SAPS II score</td></tr><tr><td>Mean white cell count</td></tr><tr><td>Mean haemoglobin</td></tr><tr><td>Mean platelet count</td></tr><tr><td>Mean [urea]</td>... | <table><tr><td>Value</td></tr><tr><td>119 ± 25 beats/minute</td></tr><tr><td>31.7 ± 8.9 breaths/minute</td></tr><tr><td>19.8 ± 7.8</td></tr><tr><td>40.2 ± 16.1</td></tr><tr><td>13.2 ± 10.1 × 109/l</td></tr><tr><td>12.4 ± 2.2 g/dl (lowest value: 7.8 g/dl)</td></tr><tr><td>217 ± 218 × 109/l</td></tr><tr><td>13.6 ± 7.6 mm... |
f2421505b4e684ba8386f6174bddff9bca71dd67df61d2574635eae887fb2291.png | complex | <table><tr><td></td><td colspan="2">Within-group difference</td><td rowspan="2">Between-group difference</td><td rowspan="2">Between-group <i>P</i>-value</td></tr><tr><td></td><td>Acu-TENS</td><td>Placebo-TENS</td></tr><tr><td>Heart rate (beat min<sup>−1</sup>)</td><td>−4.50 (0.49)</td><td>0.79 (0.21)</td><... | <table><tr><td></td><td colspan="2">Within-group difference</td><td rowspan="2">Between-group difference</td><td rowspan="2">Between-group P-value</td></tr><tr><td></td><td>Acu-TENS</td><td>Placebo-TENS</td></tr><tr><td>Heart rate (beat min−1)</td><td>−4.50 (0.49)</td><td>0.79 (0.21)</td><td>−5.29 (0.37)</td><td>.000</... | <table><tr><td></td><td colspan="2">Within-group difference</td><td rowspan="2">Between-group difference</td><td rowspan="2">Between-group P-value</td></tr><tr><td></td><td>Acu-TENS</td><td>Placebo-TENS</td></tr><tr><td>SBP (mmHg)</td><td>−4.95 (0.89)</td><td>0.35 (1.14)</td><td>−5.30 (0.85)</td><td>.206</td></tr><tr><... |
12230df13e5e2c61b772f96b5dcdc38ae65da0997c26d89e1d29c00f58280850.png | simple | <table><tr><td>Item</td><td>Home care group (n = 69)</td><td>Hospital care group (n = 69)</td><td>P</td><td>Standardized difference</td></tr><tr><td>Gender (n, male/female)</td><td>35/34</td><td>36/33</td><td>0.87</td><td>0.03</td></tr><tr><td>Age (yr, mean ± SD)</td><td>70.7 ± 13.9</td><td>70.7 ± 10.8</... | <table><tr><td>Item</td><td>Home care group (n = 69)</td><td>Hospital care group (n = 69)</td><td>P</td></tr><tr><td>Gender (n, male/female)</td><td>35/34</td><td>36/33</td><td>0.87</td></tr><tr><td>Age (yr, mean ± SD)</td><td>70.7 ± 13.9</td><td>70.7 ± 10.8</td><td>0.99</td></tr><tr><td>Primary site (n)</td><td></td><... | <table><tr><td>Standardized difference</td></tr><tr><td>0.03</td></tr><tr><td>0.002</td></tr><tr><td></td></tr><tr><td>0.08</td></tr><tr><td>0.03</td></tr><tr><td>0.07</td></tr><tr><td>0.04</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td></td></tr><tr><td>(incalculable)</td></tr><tr><td>0</td></tr><tr><td>0.06</... |
38cc3d2380ae1cd7c670ea7c7c0f26019ef548ae0b240349ea88857ccf170ad6.png | simple | <table><tr><td></td><td><i>Group 1 n = 131 (70.4%)</i></td><td><i>Group 2 n = 55 (29.6%)</i></td><td>p<i>-value</i></td><td><i>All patients</i></td></tr><tr><td>Males/females</td><td>67/64</td><td>22/33</td><td>0.199</td><td>89/97</td></tr><tr><td>Mean age (years)</td><td>53.50 ± 17.10</td><td>61.78 ± 15.38</... | <table><tr><td></td><td>Group 1 n = 131 (70.4%)</td><td>Group 2 n = 55 (29.6%)</td><td>p-value</td><td>All patients</td></tr><tr><td>Males/females</td><td>67/64</td><td>22/33</td><td>0.199</td><td>89/97</td></tr><tr><td>Mean age (years)</td><td>53.50 ± 17.10</td><td>61.78 ± 15.38</td><td>0.002*</td><td>55.94 ± 17.00</t... | <table><tr><td></td><td>Group 1 n = 131 (70.4%)</td><td>Group 2 n = 55 (29.6%)</td><td>p-value</td><td>All patients</td></tr><tr><td>Pulse pressure (mmHg)</td><td>61.54 ± 22.95</td><td>56.06 ± 18.35</td><td>0.141</td><td>60.00 ± 21.85</td></tr><tr><td>Heart rate</td><td>88.52 ± 16.45</td><td>102.58 ± 19.45</td><td>< 0.... |
0c25e394e483a1b8053e645db3f65e4ba81c100a4aad9f78026a682287b3d894.png | simple | <table><tr><td></td><td>Beta coefficient</td><td>SE</td><td>t</td><td>p-value</td></tr><tr><td>Occupation</td><td>0.558</td><td>0.187</td><td>2.98</td><td>0.003</td></tr><tr><td>Length of VMW career</td><td>0.007</td><td>0.003</td><td>2.28</td><td>0.023</td></tr><tr><td>Reason for becoming VMW</td><td>-0.649</td><td>0.... | <table><tr><td></td><td>Beta coefficient</td><td>SE</td></tr><tr><td>Occupation</td><td>0.558</td><td>0.187</td></tr><tr><td>Length of VMW career</td><td>0.007</td><td>0.003</td></tr><tr><td>Reason for becoming VMW</td><td>-0.649</td><td>0.089</td></tr><tr><td>Knowledge of malaria transmission</td><td>0.989</td><td>0.1... | <table><tr><td>t</td><td>p-value</td></tr><tr><td>2.98</td><td>0.003</td></tr><tr><td>2.28</td><td>0.023</td></tr><tr><td>-7.33</td><td><0.001</td></tr><tr><td>7.30</td><td><0.001</td></tr><tr><td>2.04</td><td>0.042</td></tr><tr><td>4.13</td><td><0.001</td></tr></table> |
0f38dd4902480b8967f71396940bd2061d1000c3c3e1eabc3b2958d7f8e7e40c.png | simple | <table><tr><td></td><td></td><td>Coverage</td><td>EC main</td><td>EC sub</td><td>EC subsub</td></tr><tr><td>RGK</td><td>TOP1</td><td>100%</td><td>22 (61.1%)</td><td>14 (38.9%)</td><td>12 (33.3%)</td></tr><tr><td></td><td>TOP3</td><td></td><td>56 (51.9%)</td><td>30 (27.8%)</td><td>24 (22.2%)</td></tr><tr><td></td><td>TO... | <table><tr><td></td><td></td><td>Coverage</td><td>EC main</td><td>EC sub</td><td>EC subsub</td></tr><tr><td>RGK</td><td>TOP1</td><td>100%</td><td>22 (61.1%)</td><td>14 (38.9%)</td><td>12 (33.3%)</td></tr><tr><td></td><td>TOP3</td><td></td><td>56 (51.9%)</td><td>30 (27.8%)</td><td>24 (22.2%)</td></tr><tr><td></td><td>TO... | <table><tr><td>TOP5</td><td>57 (51.8%)</td><td>30 (27.3%)</td><td>24 (21.8%)</td></tr></table> |
db609abdcbb2b9d82e198719c616590c48af101e91e1dd014745bc0f96ac9ec2.png | simple | <table><tr><td>Parameters</td><td>Symbol</td><td>Value</td></tr><tr><td>Duty factor</td><td><i>β</i></td><td>1/2, 4/5, 5/6</td></tr><tr><td>Turning radius</td><td><i>R<sub>turning</sub></i></td><td>600 mm, 800 mm, 1000 mm</td></tr><tr><td>Straight radius</td><td><i>R<sub>Straight</sub></i></td><td><i>Inf</i></td><... | <table><tr><td>Parameters</td><td>Symbol</td><td>Value</td></tr><tr><td>Duty factor</td><td>β</td><td>1/2, 4/5, 5/6</td></tr><tr><td>Turning radius</td><td>Rturning</td><td>600 mm, 800 mm, 1000 mm</td></tr><tr><td>Straight radius</td><td>RStraight</td><td>Inf</td></tr><tr><td>Running time</td><td>T</td><td>30 s</td></t... | <table><tr><td>The moment of straight to turning</td><td>TS-T</td><td>10 s</td></tr><tr><td>The moment of turning to straight</td><td>TT-S</td><td>20 s</td></tr><tr><td>Gait period</td><td>Tperiod</td><td>1 s</td></tr></table> |
c4877695e341530f2c4d84b23be6c761294f3e4256169ff0e3eb5ad6f33d6ce3.png | simple | <table><tr><td>Variable</td><td>Baseline</td><td>Three months</td><td><i>P</i> value</td></tr><tr><td>ESR (mean ± SD, mm in the first hour)</td><td>25.4 ± 22.4</td><td>12.8 ± 18.5</td><td>0.038</td></tr><tr><td>CRP (mean ± SD, mg/L)</td><td>17.6 ± 18.4</td><td>10.8 ± 15.9</td><td>0.058</td... | <table><tr><td>Variable</td><td>Baseline</td><td>Three months</td><td>P value</td></tr><tr><td>ESR (mean ± SD, mm in the first hour)</td><td>25.4 ± 22.4</td><td>12.8 ± 18.5</td><td>0.038</td></tr><tr><td>CRP (mean ± SD, mg/L)</td><td>17.6 ± 18.4</td><td>10.8 ± 15.9</td><td>0.058</td></tr><tr><td>Prednisone use, n (%)</... | <table><tr><td>Prednisone dose (mean ± SD, mg/day)</td><td>2.0 ± 2.5</td><td>2.8 ± 5.2</td><td>0.24</td></tr></table> |
0ae2a871a72e1a3792c6a5a3d1d7ab608cfed603860ad9a9e5aae80cde477ba4.png | simple | <table><tr><td>Article</td><td>Method</td><td>MCInc/MCIc</td><td>Scans</td><td>ACC (%)</td><td>SEN (%)</td><td>SPE (%)</td><td>AUC</td></tr><tr><td>Cui et al., 2011</td><td>Multivariate predictors (MRI, CSF, and NM scores)</td><td>87/56</td><td>baseline</td><td>67.1</td><td>96.4</td><td>48.3</td><td>0.796</td></tr><tr>... | <table><tr><td>Article</td><td>Method</td><td>MCInc/MCIc</td><td>Scans</td><td>ACC (%)</td><td>SEN (%)</td><td>SPE (%)</td><td>AUC</td></tr><tr><td>Cui et al., 2011</td><td>Multivariate predictors (MRI, CSF, and NM scores)</td><td>87/56</td><td>baseline</td><td>67.1</td><td>96.4</td><td>48.3</td><td>0.796</td></tr><tr>... | <table><tr><td></td><td></td><td>83/42</td><td>18 months</td><td>73.9</td><td>70.5</td><td>77.1</td><td>0.773</td></tr></table> |
4bece50312800a3646d2de051a6e0b72df9b7bc09f7947d24ab1018ddd35d241.png | complex | <table><tr><td colspan="2">Performance measures</td><td>Base case</td><td>Case 1</td><td>Case 2</td><td>Case 3</td><td>Case 4</td></tr><tr><td rowspan="4">Examination quantity</td><td>Total</td><td>326.9</td><td>321.3</td><td>324.6</td><td>324.0</td><td>324.0</td></tr><tr><td>Emergency patients</td><td>132.6</td><td>13... | <table><tr><td colspan="2">Performance measures</td><td>Base case</td><td>Case 1</td><td>Case 2</td><td>Case 3</td><td>Case 4</td></tr><tr><td rowspan="4">Examination quantity</td><td>Total</td><td>326.9</td><td>321.3</td><td>324.6</td><td>324.0</td><td>324.0</td></tr><tr><td>Emergency patients</td><td>132.6</td><td>13... | <table><tr><td colspan="2">Performance measures</td><td>Base case</td><td>Case 1</td><td>Case 2</td><td>Case 3</td><td>Case 4</td></tr><tr><td rowspan="3">Wait time (min)</td><td>Emergency patients</td><td>1.8</td><td>2.0</td><td>1.9</td><td>2.0</td><td>1.9</td></tr><tr><td>Outpatients</td><td>96.6</td><td>53.6</td><td... |
95b8a3a3f242ad386172926be280af7601d18fe98f5cf6580875cffdd65c0937.png | simple | <table><tr><td></td><td>kappa</td></tr><tr><td>presence of activity periods</td><td>0.905*</td></tr><tr><td>presence of rhythmical activity</td><td>0.786*</td></tr><tr><td></td><td>ICC (95% CI)</td></tr><tr><td>amount of activity periods</td><td>0.967 (0.951–0.978)*</td></tr><tr><td>dominant frequency</td><td>0.7... | <table><tr><td></td></tr><tr><td>presence of activity periods</td></tr><tr><td>presence of rhythmical activity</td></tr><tr><td></td></tr><tr><td>amount of activity periods</td></tr><tr><td>dominant frequency</td></tr><tr><td>second prevalent frequency</td></tr><tr><td>third prevalent frequency</td></tr><tr><td>minimal... | <table><tr><td>kappa</td></tr><tr><td>0.905*</td></tr><tr><td>0.786*</td></tr><tr><td>ICC (95% CI)</td></tr><tr><td>0.967 (0.951–0.978)*</td></tr><tr><td>0.739 (0.624–0.822)*</td></tr><tr><td>0.787 (0.672–0.864)*</td></tr><tr><td>0.789 (0.672–0.867)*</td></tr><tr><td>0.351 (0.149–0.525)#</td></tr><tr><td>0.831 (0.750–0... |
c8e4a6b728fe3360f39f0924b3106bf7f04fb0e8e7fe5961c7006987e94174ae.png | simple | <table><tr><td>Theory</td><td>Favourable impact of coach change on team performance</td><td>Slope of the favourable impact over time</td></tr><tr><td>Vicious-circle theory</td><td>NO</td><td></td></tr><tr><td>Ritual scapegoating theory</td><td>NO</td><td></td></tr><tr><td>Common-sense theory</td><td>YES</td><td>=</td><... | <table><tr><td>Theory</td><td>Favourable impact of coach change on team performance</td></tr><tr><td>Vicious-circle theory</td><td>NO</td></tr><tr><td>Ritual scapegoating theory</td><td>NO</td></tr><tr><td>Common-sense theory</td><td>YES</td></tr><tr><td>Current study</td><td>YES</td></tr></table> | <table><tr><td>Slope of the favourable impact over time</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>=</td></tr><tr><td>> in the short term and= in the long term</td></tr></table> |
0420441f3594304649b7c3004daf0e7eea9b5ac2e3d2a1fb2def706b1ab08593.png | simple | <table><tr><td>Normal versus tumor biomarkers</td><td>LN negative versus LN positive biomarkers</td></tr><tr><td><i>SLC39A5</i>, <i>C3orf32</i>, <i>TP73</i>, <i>CD1B</i>, <i>PCDHGA4</i>, <i>PCDHGA11</i>, <i>PCDHGA9</i>, <i>PCDHGA1</i>, <i>PCDHGB1</i>, <i>PCDHGB6</i>, <i>PCDHGA12</i>, <i>PCDHGB3</i>, <i>PCDHGB7</i>, <i>... | <table><tr><td>Normal versus tumor biomarkers</td><td>LN negative versus LN positive biomarkers</td></tr></table> | <table><tr><td>SLC39A5, C3orf32, TP73, CD1B, PCDHGA4, PCDHGA11, PCDHGA9, PCDHGA1, PCDHGB1, PCDHGB6, PCDHGA12, PCDHGB3, PCDHGB7, PCDHGA6, PCDHGA8, PCDHGA10, PCDHGA5, PCDHGB4, PCDHGA3, PCDHGA2, PCDHGB2, PCDHGA7, PCDHGB5, C20orf197, SLC16A5, FUT8, SLC15A2, C17orf93, PRAC, OCLN, TMEM144, FGF2, PDX1, CCL1, LILRB5, LCE3D, GP... |
6e770653677e66e9f4ef316b8c5c909c4137789e12bc42ff7e736aa2a083ede5.png | complex | <table><tr><td rowspan="2">Phytoestrogen</td><td>Corr CC</td><td rowspan="2"><i>p</i>-Value</td><td>Corr CC</td><td rowspan="2"><i>p</i>-Value</td></tr><tr><td>Habitual (μg/Day) vs. Urine (μg/g Creatinine)</td><td>Recent (μg/Day) vs. Urine (μg/g Creatinine)</td></tr><tr><td>Daidzein</td><td>−0... | <table><tr><td rowspan="2">Phytoestrogen</td><td>Corr CC</td><td rowspan="2">p-Value</td><td>Corr CC</td><td rowspan="2">p-Value</td></tr><tr><td>Habitual (μg/Day) vs. Urine (μg/g Creatinine)</td><td>Recent (μg/Day) vs. Urine (μg/g Creatinine)</td></tr><tr><td>Daidzein</td><td>−0.024</td><td>0.840</td><td>0.099</td><td... | <table><tr><td rowspan="2">Phytoestrogen</td><td>Corr CC</td><td rowspan="2">p-Value</td><td>Corr CC</td><td rowspan="2">p-Value</td></tr><tr><td>Habitual (μg/Day) vs. Urine (μg/g Creatinine)</td><td>Recent (μg/Day) vs. Urine (μg/g Creatinine)</td></tr><tr><td>Naringenin</td><td>0.069</td><td>0.571</td><td>0.620</td><t... |
311fe71e3999a1b4acd1719a75434739ccffeee0118a4477ee49851fc73c5fb0.png | simple | <table><tr><td>Viruses detected</td><td>Patients with acute diarrhea (N = 145) (%)</td></tr><tr><td>Norovirus GII</td><td>59 (40.7)</td></tr><tr><td>Norovirus GI</td><td>17 (11.7)</td></tr><tr><td>Astrovirus</td><td>5 (3.5)</td></tr><tr><td>Rotavirus</td><td>2 (1.4)</td></tr><tr><td>Adenovirus 40/41</td><td>0 (0.0)</td... | <table><tr><td>Viruses detected</td><td>Patients with acute diarrhea (N = 145) (%)</td></tr><tr><td>Norovirus GII</td><td>59 (40.7)</td></tr><tr><td>Norovirus GI</td><td>17 (11.7)</td></tr><tr><td>Astrovirus</td><td>5 (3.5)</td></tr><tr><td>Rotavirus</td><td>2 (1.4)</td></tr><tr><td>Adenovirus 40/41</td><td>0 (0.0)</td... | <table><tr><td>Norovirus GII + Astrovirus</td><td>4 (2.8)</td></tr><tr><td>At least one virus detected</td><td>94 (64.8)</td></tr><tr><td>No virus detected</td><td>51 (35.2)</td></tr></table> |
51028004166ae07414b1b400c980787a9f504b527ee86ecf9f23e65a86e8db11.png | simple | <table><tr><td> </td><td>Lab #1 (Sequencing)</td><td>Lab #2 (Sequencing)</td><td>Lab #3 (Sequencing)</td><td>Lab #4 (Primer Extension)</td><td>Lab #5 (Real Time PCR)</td></tr><tr><td>Specimen Requirements</td><td>Preferred sample type*:Slides from FFPE block 1H&E stained slide sections with tumor circled; 4 matchin... | <table><tr><td></td><td>Lab #1 (Sequencing)</td><td>Lab #2 (Sequencing)</td><td>Lab #3 (Sequencing)</td><td>Lab #4 (Primer Extension)</td></tr><tr><td>Specimen Requirements</td><td>Preferred sample type*:Slides from FFPE block 1H&E stained slide sections with tumor circled; 4 matching unstained slides,10 microns each.<... | <table><tr><td>Lab #5 (Real Time PCR)</td></tr><tr><td>Preferred sample type: FFPE block, unstained slides, or fresh snap frozen biopsy 5 unstained sections, 7 microns each</td></tr><tr><td>Methods are propietary: qualitative real time PCR Detected mutations: KRAS codons 12 and 13</td></tr><tr><td>1-5%</td></tr></table... |
8a6fe8bcb6a5634a8ffc1ad85167788294fe3b3d97e6dc947df096e2ed891459.png | simple | <table><tr><td>Behavior</td><td>HIV positives</td></tr><tr><td>Had sex past year</td><td>71.3</td></tr><tr><td>Had steady partner past year</td><td>50.3</td></tr><tr><td>Used condoms with steady partner past month</td><td> </td></tr><tr><td>Never</td><td>47.7</td></tr><tr><td>Seldom</td><td>23.9</td></tr><tr><td>Often<... | <table><tr><td>Behavior</td><td>HIV positives</td></tr><tr><td>Had sex past year</td><td>71.3</td></tr><tr><td>Had steady partner past year</td><td>50.3</td></tr><tr><td>Used condoms with steady partner past month</td><td></td></tr><tr><td>Never</td><td>47.7</td></tr><tr><td>Seldom</td><td>23.9</td></tr><tr><td>Often</... | <table><tr><td>Seldom</td><td>22.5</td></tr><tr><td>Often</td><td>13.5</td></tr><tr><td>Always</td><td>21.6</td></tr><tr><td>Sold sex last year</td><td>2.7</td></tr><tr><td>Purchased sex last year</td><td>20.0</td></tr><tr><td>Condom use with FSW last month</td><td></td></tr><tr><td>Never</td><td>45.2</td></tr><tr><td>... |
583f07c427a646a496f521f37a56f54ca52f12ef1f5b11b78d05bf375b1e939a.png | complex | <table><tr><td></td><td>CspA</td><td>CspZ</td><td>ErpP<sup>a</sup></td><td>ErpC<sup>a</sup></td><td>ErpA<sup>a</sup></td><td>p43</td><td>BBK32</td><td>BGA66</td><td>BGA71</td><td>CD59-like protein</td></tr><tr><td rowspan="7">Synonyms and other designations</td><td>CRASP-1</td><td>CRASP-2</td><td>CRASP-3</td><td>CRASP-... | <table><tr><td></td><td>CspA</td><td>CspZ</td><td>ErpPa</td><td>ErpCa</td><td>ErpAa</td><td>p43</td><td>BBK32</td><td>BGA66</td><td>BGA71</td><td>CD59-like protein</td></tr><tr><td rowspan="7">Synonyms and other designations</td><td>CRASP-1</td><td>CRASP-2</td><td>CRASP-3</td><td>CRASP-4</td><td>CRASP-5</td><td rowspan... | <table><tr><td>Affected complement pathways</td><td>AP, TP</td><td>AP</td><td>–</td><td>–</td><td>–</td><td>CP/LP(?)</td><td>CP</td><td>TP</td><td>TP</td><td>TP</td></tr></table> |
998783c085d5745756c2069d766c316a3ebf9679b700ddd4a8ea302c8929c5fc.png | simple | <table><tr><td></td><td>Danish early-vaccination era data set</td><td>Global post-vaccination era data set</td></tr><tr><td>Length of sequences</td><td>800</td><td>800</td></tr><tr><td>Number of sequences</td><td>18</td><td>40</td></tr><tr><td>Average number of differences</td><td>12.2</td><td>31.0</td></tr><tr><td># s... | <table><tr><td></td><td>Danish early-vaccination era data set</td><td>Global post-vaccination era data set</td></tr><tr><td>Length of sequences</td><td>800</td><td>800</td></tr><tr><td>Number of sequences</td><td>18</td><td>40</td></tr></table> | <table><tr><td></td><td>Danish early-vaccination era data set</td><td>Global post-vaccination era data set</td></tr><tr><td>Average number of differences</td><td>12.2</td><td>31.0</td></tr><tr><td># synonymous substitutions</td><td>26</td><td>131</td></tr><tr><td># non-synonymous substitutions</td><td>32</td><td>71</td... |
6768068831201205219a4d26ec0998e852e1d8ede6cf906dfb265813f3882be8.png | complex | <table><tr><td></td><td colspan="2">Cholelithiasis</td><td></td><td></td><td></td></tr><tr><td></td><td>Yes(n = 3725)</td><td>No(n = 11175)</td><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>Obesity</td><td>30 (0.81%)</td><td>42 (0.38%)</td><td>2.16</td><td>1.35 - 3.45</td><td>0.001*</td></tr><tr><td>Diabetes m... | <table><tr><td></td><td colspan="2">Cholelithiasis</td><td></td><td></td><td></td></tr><tr><td></td><td>Yes(n = 3725)</td><td>No(n = 11175)</td><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>Obesity</td><td>30 (0.81%)</td><td>42 (0.38%)</td><td>2.16</td><td>1.35 - 3.45</td><td>0.001*</td></tr></table> | <table><tr><td></td><td colspan="2">Cholelithiasis</td><td></td><td></td><td></td></tr><tr><td></td><td>Yes(n = 3725)</td><td>No(n = 11175)</td><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>Diabetes mellitus</td><td>513 (13.77%)</td><td>1 236 (11.06%)</td><td>1.31</td><td>1.17 - 1.47</td><td>< 0.001*</td></tr>... |
8784bc5b36f867da68b7a9b2f418cacb6ef44b562b5423173afec7f524fae0d4.png | simple | <table><tr><td>Characteristics</td><td><i>Number </i>(%)</td><td>Characteristics</td><td><i>Number </i>(%)</td></tr><tr><td>Kebele</td><td> </td><td>Religion</td><td> </td></tr><tr><td> Yikaho</td><td>63(15.1)</td><td>Orthodox Christian</td><td>337(80.6)</td></tr><tr><td> Mahdid</td><td>62(14.8)</td><td>Muslims</td><td... | <table><tr><td>Characteristics</td></tr><tr><td>Kebele</td></tr><tr><td>Yikaho</td></tr><tr><td>Mahdid</td></tr><tr><td>Bambaho</td></tr><tr><td>Dubaba</td></tr><tr><td>Gender</td></tr><tr><td>Male</td></tr><tr><td>Female</td></tr><tr><td>Age (years)</td></tr><tr><td>18-24</td></tr><tr><td>25-49</td></tr><tr><td>50-64<... | <table><tr><td>Number (%)</td><td>Characteristics</td><td>Number (%)</td></tr><tr><td></td><td>Religion</td><td></td></tr><tr><td>63(15.1)</td><td>Orthodox Christian</td><td>337(80.6)</td></tr><tr><td>62(14.8)</td><td>Muslims</td><td>81(19.4)</td></tr><tr><td>126(30.1)</td><td>Educational level</td><td></td></tr><tr><t... |
8bba829f4e301c5ee01f0674d86aff30b3ec9a7ec4ffc68ede976ec9e577aff9.png | complex | <table><tr><td>Protein</td><td>Gene</td><td>Hz vs WT (fold change)</td><td><i>P</i> value</td><td>Hz + IGF-1 vs Hz (fold change)</td><td><i>P</i> value</td></tr><tr><td colspan="6">IGF-1R and Intracellular signaling</td></tr><tr><td> Insulin-like growth factor 1 receptor</td><td><i>igf1r</i></td><td>1.44</td><td>0.0001... | <table><tr><td>Protein</td><td>Gene</td><td>Hz vs WT (fold change)</td><td>P value</td><td>Hz + IGF-1 vs Hz (fold change)</td><td>P value</td></tr><tr><td colspan="6">IGF-1R and Intracellular signaling</td></tr><tr><td>Insulin-like growth factor 1 receptor</td><td>igf1r</td><td>1.44</td><td>0.0001</td><td>1.29</td><td>... | <table><tr><td>Secreted phosphoprotein 1</td><td>spp1</td><td>2.44</td><td>0.001</td><td>−1.80</td><td>0.005</td></tr><tr><td>Allograft inflammatory factor 1</td><td>aif1</td><td>1.95</td><td>0.0001</td><td>−2.82</td><td>0.00006</td></tr><tr><td>Apoptotic peptidase activating factor 1</td><td>apaf</td><td>1.05</td><td>... |
91d5e0c25b710cf574e522dbb09fc5cc35882ea6ed8f8de9c3a802bee52aed6a.png | simple | <table><tr><td>Animal</td><td>Model</td><td>Preconditioning time/approach</td><td>TLR/ischemia</td><td>Result and mechanism</td><td>Author</td><td>Reference</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>72 h/12-min ischemia</td><td>Ischemic preconditioning</td><td>Decrease brain infarcti... | <table><tr><td>Animal</td><td>Model</td><td>Preconditioning time/approach</td><td>TLR/ischemia</td><td>Result and mechanism</td><td>Author</td><td>Reference</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>72 h/12-min ischemia</td><td>Ischemic preconditioning</td><td>Decrease brain infarcti... | <table><tr><td>Animal</td><td>Model</td><td>Preconditioning time/approach</td><td>TLR/ischemia</td><td>Result and mechanism</td><td>Author</td><td>Reference</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>1 h/IP</td><td>TLR3 poly-IC</td><td>Decrease brain infarction and prevention of Fas/F... |
cde8bb1980614675d9148428adc87a9d278fbb74feae5448597cdc211d81b231.png | complex | <table><tr><td>Variable</td><td>Category</td><td>A/A</td><td>G/A</td><td>Total</td><td><i>P</i> value</td></tr><tr><td rowspan="2">Surfactant</td><td>Yes</td><td>26 (92.9%)</td><td>2 (7.1%)</td><td>28 (100%)</td><td rowspan="2">0.271</td></tr><tr><td>No</td><td>174 (82.9%)</td><td>36 (17.1%)</td><td>210 (100%)</td></tr... | <table><tr><td>Variable</td><td>Category</td><td>A/A</td><td>G/A</td><td>Total</td><td>P value</td></tr><tr><td>Surfactant</td><td>Yes</td><td>26 (92.9%)</td><td>2 (7.1%)</td><td>28 (100%)</td><td>0.271</td></tr></table> | <table><tr><td>Surfactant</td><td>No</td><td>174 (82.9%)</td><td>36 (17.1%)</td><td>210 (100%)</td><td>0.271</td></tr><tr><td rowspan="2">Ventilator</td><td>Yes</td><td>31 (93.9%)</td><td>2 (6.1%)</td><td>33 (100%)</td><td rowspan="2">0.094</td></tr><tr><td>No</td><td>169 (82.4%)</td><td>36 (17.6%)</td><td>205 (100%)</... |
818dbd9e0f573af20c0f1f0bcdaeaa95ae552de592145c73ab1ce71db5bf4efd.png | simple | <table><tr><td>Sl. number</td><td>Age</td><td>Gender</td><td>Site</td><td>Size</td><td>Histopathological category</td></tr><tr><td>Case1</td><td>40</td><td>Female</td><td>Gingiva</td><td>1-2 cm</td><td>Cellular phase</td></tr><tr><td>Case2</td><td>40</td><td>Female</td><td>Buccal mucosa</td><td>1-2 cm</td><td>Capillary... | <table><tr><td>Sl. number</td><td>Age</td><td>Gender</td><td>Site</td><td>Size</td><td>Histopathological category</td></tr><tr><td>Case1</td><td>40</td><td>Female</td><td>Gingiva</td><td>1-2 cm</td><td>Cellular phase</td></tr><tr><td>Case2</td><td>40</td><td>Female</td><td>Buccal mucosa</td><td>1-2 cm</td><td>Capillary... | <table><tr><td>Sl. number</td><td>Age</td><td>Gender</td><td>Site</td><td>Size</td><td>Histopathological category</td></tr><tr><td>Case4</td><td>23</td><td>Female</td><td>Gingiva</td><td>1-2 cm</td><td>Involutionary phase</td></tr></table> |
f47cff45be410019c55f9fd45580c89899b493c5a50c51b650bc7ad59482fd7e.png | complex | <table><tr><td>Population</td><td>Region of interest</td><td>E<sub>max</sub>, %</td><td>EC<sub>50</sub>, ng/mL</td></tr><tr><td rowspan="3">EC</td><td>Hippocampus</td><td>89.1 (CV%: 9.6)</td><td>2.05 (CV%: 33.4)</td></tr><tr><td>Striatum</td><td>88.8 (CV%: 7.5)</td><td>1.67 (CV%: 29.7)</td></tr><tr><td>Frontal cortex</... | <table><tr><td>Population</td><td>Region of interest</td><td>Emax, %</td><td>EC50, ng/mL</td></tr><tr><td rowspan="3">EC</td><td>Hippocampus</td><td>89.1 (CV%: 9.6)</td><td>2.05 (CV%: 33.4)</td></tr><tr><td>Striatum</td><td>88.8 (CV%: 7.5)</td><td>1.67 (CV%: 29.7)</td></tr><tr><td>Frontal cortex</td><td>80.1 (CV%: 8.9)... | <table><tr><td>Population</td><td>Region of interest</td><td>Emax, %</td><td>EC50, ng/mL</td></tr><tr><td>AD</td><td>Frontal cortex</td><td>81.1 (CV%: 3.2)</td><td>1.06 (CV%: 19.6)</td></tr></table> |
90558615782c6f66262e92b9101d3b3493759320c01998073eaffe07468c880b.png | simple | <table><tr><td>Factors</td><td>Moxi</td><td>(%)</td><td>Non-Moxi</td><td>(%)</td></tr><tr><td>Number</td><td>276</td><td> </td><td>1992</td><td> </td></tr><tr><td>Age</td><td>44.78</td><td> </td><td>38.5</td><td> </td></tr><tr><td>Sex (male)</td><td>150</td><td>(54.3)</td><td>1129</td><td>(56.7)</td></tr><tr><td>Site o... | <table><tr><td>Factors</td><td>Moxi</td><td>(%)</td><td>Non-Moxi</td><td>(%)</td></tr><tr><td>Number</td><td>276</td><td></td><td>1992</td><td></td></tr><tr><td>Age</td><td>44.78</td><td></td><td>38.5</td><td></td></tr><tr><td>Sex (male)</td><td>150</td><td>(54.3)</td><td>1129</td><td>(56.7)</td></tr><tr><td>Site of di... | <table><tr><td>Factors</td><td>Moxi</td><td>(%)</td><td>Non-Moxi</td><td>(%)</td></tr><tr><td>Overseas</td><td>254</td><td>92.0</td><td>1773</td><td>89.0</td></tr><tr><td>HIV status</td><td></td><td></td><td></td><td></td></tr><tr><td>Positive</td><td>5</td><td>1.8</td><td>32</td><td>1.6</td></tr><tr><td>Negative</td><... |
822a4d6aac4df167fe17e75188c816374dafd8b815267ea562b536cdcd56773a.png | complex | <table><tr><td>Sample</td><td>Spiked Level (mg/kg)</td><td>Recovery (%)</td><td>RSD <sup>a</sup> (%)</td></tr><tr><td rowspan="3">fresh tea leaf</td><td>0.01</td><td>92.3 ± 6.51</td><td>10.2</td></tr><tr><td>0.05</td><td>84.3 ± 5.84</td><td>10.4</td></tr><tr><td>0.5</td><td>77.7 ± 4.67</td><td>8.6</td></... | <table><tr><td>Sample</td><td>Spiked Level (mg/kg)</td><td>Recovery (%)</td><td>RSD a (%)</td></tr><tr><td rowspan="2">fresh tea leaf</td><td>0.01</td><td>92.3 ± 6.51</td><td>10.2</td></tr><tr><td>0.05</td><td>84.3 ± 5.84</td><td>10.4</td></tr></table> | <table><tr><td>fresh tea leaf</td><td>0.5</td><td>77.7 ± 4.67</td><td>8.6</td></tr></table> |
2fdf7984d613489942e5707230b2feda384cfd4fbdf95319a202c55b514733e0.png | complex | <table><tr><td rowspan="2">Fractions/compounds</td><td colspan="4">IC<sub>50</sub>(μg/ml)</td></tr><tr><td>LLC</td><td>A2780</td><td>HepG2</td><td>A549</td></tr><tr><td>HE</td><td>660.11 ± 16.71</td><td>246.97 ± 18.78</td><td>288.95 ± 17.84</td><td>294.96 ± 24.46</td></tr><tr><td>WE</td><td>614... | <table><tr><td>Fractions/compounds</td><td colspan="4">IC50(μg/ml)</td></tr></table> | <table><tr><td>Fractions/compounds</td><td>LLC</td><td>A2780</td><td>HepG2</td><td>A549</td></tr><tr><td>HE</td><td>660.11 ± 16.71</td><td>246.97 ± 18.78</td><td>288.95 ± 17.84</td><td>294.96 ± 24.46</td></tr><tr><td>WE</td><td>614.74 ± 19.55</td><td>208.38 ± 23.57</td><td>279.09 ± 13.06</td><td>461.26 ± 28.38</td></tr... |
f13f667de8281cb7bb22d86da6cdaeb3a2985f535fae177447fdb44a4209fa04.png | complex | <table><tr><td>FGD content analysis</td><td>Men – young FGD</td></tr><tr><td>Meaning unit</td><td>I think smoking is not related to sugar disease but there must be small part that can affect sugar disease; most smokers, including me, we usually deny</td></tr><tr><td>Condensed meaning unit</td><td>Smoking is relat... | <table><tr><td>FGD content analysis</td><td>Men – young FGD</td></tr><tr><td>Meaning unit</td><td>I think smoking is not related to sugar disease but there must be small part that can affect sugar disease; most smokers, including me, we usually deny</td></tr><tr><td>Condensed meaning unit</td><td>Smoking is related to ... | <table><tr><td>Codes</td><td>Aware of healthy lifestyle but ignoring</td></tr><tr><td rowspan="6">Codes cluster</td><td>Diabetes content area:</td></tr><tr><td>-</td></tr><tr><td>Risk factors content area:</td></tr><tr><td>Smoking only partly related to diabetes</td></tr><tr><td>Smokers deny bad effect of smoking</td><... |
04c3e16c09cd9be10e0b1d09f24e7a00d90061101bd73c2358ff90e99bdd4432.png | simple | <table><tr><td>Plate temperature <i>T</i><sub><i>w </i></sub> (K)</td><td>RaK</td><td>Nu</td><td>Nu<sub>avg</sub></td><td>Nu/RaK<sup>0.5</sup></td><td>Nu/RaK<sup>0.5</sup>[[1-4]]</td></tr><tr><td>303</td><td>69.5325</td><td>3.6319</td><td>6.6569</td><td>0.4356</td><td>≈0.44</td></tr><tr><td>313</td><td>139.0649</... | <table><tr><td>Plate temperature Tw (K)</td><td>RaK</td><td>Nu</td><td>Nuavg</td><td>Nu/RaK0.5</td><td>Nu/RaK0.5[[1-4]]</td></tr><tr><td>303</td><td>69.5325</td><td>3.6319</td><td>6.6569</td><td>0.4356</td><td>≈0.44</td></tr><tr><td>313</td><td>139.0649</td><td>5.0880</td><td>8.959</td><td>0.4315</td><td>0.44</td></tr... | <table><tr><td>33</td><td>278.1298</td><td>2200</td><td>11.8779</td><td>9</td><td>4</td></tr><tr><td>353</td><td>417.2597</td><td>8.8231</td><td>13.8479</td><td>0.4320</td><td>0.44</td></tr><tr><td>373</td><td>556.2597</td><td>10.1248</td><td>15.3437</td><td>0.43</td><td>0.44</td></tr></table> |
057d27600b9223d410a47295f77a5ee583be9c44a63dc10cde5ff6ff130667d1.png | complex | <table><tr><td>Ligand</td><td colspan="2"><i>Mutagenicity</i></td><td colspan="3"><i>Carcinogenicity</i></td></tr><tr><td></td><td><i>Salmonella typhimurium</i>(CPDB)</td><td><i>Salmonella typhimurium</i>(Kazius/Bursi)</td><td><i>Rodent</i>(<i>multiple sex</i>)</td><td><i>Rat</i>(<i>both sex</i>)</td><td><i>Mouse</i>(<... | <table><tr><td>Ligand</td><td colspan="2">Mutagenicity</td><td colspan="3">Carcinogenicity</td></tr><tr><td></td><td>Salmonella typhimurium(CPDB)</td><td>Salmonella typhimurium(Kazius/Bursi)</td><td>Rodent(multiple sex)</td><td>Rat(both sex)</td><td>Mouse(both sex)</td></tr><tr><td>SAHA</td><td>no</td><td>no</td><td>no... | <table><tr><td>Ligand</td><td colspan="2">Mutagenicity</td><td colspan="3">Carcinogenicity</td></tr><tr><td></td><td>Salmonella typhimurium(CPDB)</td><td>Salmonella typhimurium(Kazius/Bursi)</td><td>Rodent(multiple sex)</td><td>Rat(both sex)</td><td>Mouse(both sex)</td></tr><tr><td>1b</td><td>no</td><td>no</td><td>no</... |
3c77707be995a952e19c94fc508a014ecc8e774ed758236afca144d8f61d9101.png | simple | <table><tr><td>Variable</td><td>n(%) n = 105</td></tr><tr><td>Age (mean(SD))</td><td>63.4 (20.1)</td></tr><tr><td>Age category</td><td>-</td></tr><tr><td>20–49</td><td>24(23)</td></tr><tr><td>50–74</td><td>38(36)</td></tr><tr><td>75–84</td><td>25(24)</td></tr><tr><td>85+</td><td>18(17)</td></tr><tr><t... | <table><tr><td>V</td><td>n(</td></tr></table> | <table><tr><td>ariable</td><td>%) n = 105</td></tr><tr><td>Age (mean(SD))</td><td>63.4 (20.1)</td></tr><tr><td>Age category</td><td>-</td></tr><tr><td>20–49</td><td>24(23)</td></tr><tr><td>50–74</td><td>38(36)</td></tr><tr><td>75–84</td><td>25(24)</td></tr><tr><td>85+</td><td>18(17)</td></tr><tr><td>Female</td><td>67(6... |
766efaa3f81afbc802d8d51bd6beb18b4d64fc5d73dcbf17a133c8169a666ede.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">msSNP</td><td colspan="4">Location error by the composite likelihood approach</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td colspan="2">Causal SNP out</td><td colspan="2">Causal SNP in</td></tr><tr><td>SNP density (kb/SNP)</td><td>No. SNPs</td><td>No... | <table><tr><td></td><td></td><td></td><td colspan="2">msSNP</td><td colspan="4">Location error by the composite likelihood approach</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td colspan="2">Causal SNP out</td><td colspan="2">Causal SNP in</td></tr><tr><td>SNP density (kb/SNP)</td><td>No. SNPs</td><td>No... | <table><tr><td>Full (11)</td><td>15701</td><td>126</td><td>2324</td><td>153</td><td>57</td><td>13</td><td>55</td><td>14</td></tr><tr><td>1/2 (22)</td><td>7850</td><td>125</td><td>1762</td><td>-2</td><td>5</td><td>-19</td><td>5</td><td>-20</td></tr><tr><td>1/3 (33)</td><td>5233</td><td>118</td><td>2324</td><td>153</td><... |
8eb2e0ea85a446baeba9b8de2bb554e8e7bb4c31833444ccf9e00ea17cb164b1.png | complex | <table><tr><td rowspan="2">Epidemiological and demographic variable</td><td colspan="2">Number of cases</td><td>Deaths</td><td>Case fatality rate</td><td>Incidence rate</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>/100,000</td></tr><tr><td colspan="6">Region of probable infection site</td></tr><tr><td> Nort... | <table><tr><td rowspan="2">Epidemiological and demographic variable</td><td colspan="2">Number of cases</td><td>Deaths</td><td>Case fatality rate</td><td>Incidence rate</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>/100,000</td></tr><tr><td colspan="6">Region of probable infection site</td></tr><tr><td>North... | <table><tr><td>Periurban</td><td>110</td><td>6.3</td><td>48</td><td>42.7</td><td>–</td></tr><tr><td>Left blank or unknown</td><td>230</td><td>13.1</td><td>108</td><td>51.3</td><td>–</td></tr><tr><td colspan="6">Gender</td></tr><tr><td>Male</td><td>1338</td><td>76.4</td><td>503</td><td>37.6</td><td>0.04</td></tr><tr><td... |
02818efcd34f705ea0365b81f547c34240e54a427cfe9265b24d53dd72c4d02b.png | complex | <table><tr><td></td><td colspan="2">Univariate</td><td colspan="2">Multivariate<sup>a</sup></td></tr><tr><td>Group</td><td>OR (95 % CI)</td><td><i>P</i></td><td>OR (95 % CI)</td><td><i>P</i></td></tr><tr><td>Moderate to severe hypoatremia</td><td>1.91 (1.197–3.033)</td><td>0.007</td><td>3.61 (1.438–9.049)</... | <table><tr><td></td><td colspan="2">Univariate</td><td colspan="2">Multivariatea</td></tr><tr><td>Group</td><td>OR (95 % CI)</td><td>P</td><td>OR (95 % CI)</td><td>P</td></tr><tr><td>Moderate to severe hypoatremia</td><td>1.91 (1.197–3.033)</td><td>0.007</td><td>3.61 (1.438–9.049)</td><td>0.006</td></tr></table> | <table><tr><td></td><td colspan="2">Univariate</td><td colspan="2">Multivariatea</td></tr><tr><td>Group</td><td>OR (95 % CI)</td><td>P</td><td>OR (95 % CI)</td><td>P</td></tr><tr><td>Mild hyponatremia</td><td>1.65 (1.047–2.610)</td><td>0.031</td><td>2.45 (1.051–5.705)</td><td>0.038</td></tr><tr><td>Normonatremia</td><t... |
eb0b44c00e8cdc5494401f92df47b04d416a64b733263f20b555b3d6143da21a.png | simple | <table><tr><td></td><td>No incident diabetes (n = 2590)</td><td>Incident diabetes (n = 297)</td><td>p≤*</td></tr><tr><td>Age (years)</td><td>44 ± 17</td><td>47 ± 15</td><td>0.101</td></tr><tr><td>Sex (% women)</td><td>60</td><td>61</td><td>0.662</td></tr><tr><td>Systolic BP (mmHg)</td><td>122 ± 17<... | <table><tr><td></td><td>No incident diabetes (n = 2590)</td><td>Incident diabetes (n = 297)</td><td>p≤*</td></tr><tr><td>Age (years)</td><td>44 ± 17</td><td>47 ± 15</td><td>0.101</td></tr><tr><td>Sex (% women)</td><td>60</td><td>61</td><td>0.662</td></tr><tr><td>Systolic BP (mmHg)</td><td>122 ± 17</td><td>127 ± 17</td>... | <table><tr><td>PAI-1 (mg/dL)</td><td>42 [26–65]</td><td>58 [38–93]</td><td>0.01†</td></tr><tr><td>Fat-free mass (kg)</td><td>53 ± 12</td><td>59 ± 14</td><td>0.04</td></tr><tr><td>Adipose mass (kg)</td><td>35 ± 10</td><td>40 ± 8</td><td>0.0001</td></tr><tr><td>LVDD index (cm/m)</td><td>3.09 ± 0.25</td><td>3.16 ± 0.29</t... |
dc334b8fe329e1c29c364d9584abb90fc87389f2e4e2692fde6afeb6090fc4de.png | complex | <table><tr><td></td><td colspan="2">NH White</td><td colspan="2">NH Black</td><td colspan="2">Hispanic</td><td colspan="2">Asian/PI</td></tr><tr><td></td><td><i>n</i>=11,347</td><td>86.92%</td><td><i>n</i>=772</td><td>5.91%</td><td><i>n</i>=601</td><td>4.60%</td><td><i>n</i>=334</td><td>2.56%</td></tr><tr><td colspan="... | <table><tr><td></td><td colspan="2">NH White</td><td colspan="2">NH Black</td></tr><tr><td></td><td>n=11,347</td><td>86.92%</td><td>n=772</td><td>5.91%</td></tr><tr><td colspan="5">Screening service</td></tr><tr><td colspan="5">Well visit (n = 13,054)</td></tr><tr><td>Yes (%)</td><td>1374</td><td>12.11</td><td>78</td><... | <table><tr><td colspan="2">Hispanic</td><td colspan="2">Asian/PI</td></tr><tr><td>n=601</td><td>4.60%</td><td>n=334</td><td>2.56%</td></tr><tr><td colspan="4">Screening service</td></tr><tr><td colspan="4">Well visit (n = 13,054)</td></tr><tr><td>70</td><td>11.65</td><td>49</td><td>14.67</td></tr><tr><td>0.96</td><td>0... |
26d68574acead4ff5561b7b536cb9147456b2f1da33355d0d08c6136b299525b.png | complex | <table><tr><td>Prognostic feature</td><td>P value</td><td>OR</td><td colspan="2">95% CI</td></tr><tr><td>Gender [male/female]</td><td>0.185</td><td>2.745</td><td>0.618</td><td>12.193</td></tr><tr><td>ECOG 1 vs. 0</td><td>0.020</td><td>0.336</td><td>0.134</td><td>0.842</td></tr><tr><td>ECOG 2 vs. 0</td><td>0.047</td><td... | <table><tr><td>Prognostic feature</td><td>P value</td><td>OR</td><td colspan="2">95% CI</td></tr><tr><td>Gender [male/female]</td><td>0.185</td><td>2.745</td><td>0.618</td><td>12.193</td></tr><tr><td>ECOG 1 vs. 0</td><td>0.020</td><td>0.336</td><td>0.134</td><td>0.842</td></tr><tr><td>ECOG 2 vs. 0</td><td>0.047</td><td... | <table><tr><td>ing [y/n]</td><td>.165</td><td></td><td>7</td><td>1</td></tr><tr><td>Radiation therapy [y/n]</td><td>0.999</td><td>0</td><td>0</td><td>.</td></tr><tr><td>Symptoms [y/n]</td><td>0.109</td><td>0.458</td><td>0.176</td><td>1.192</td></tr><tr><td>Urge [y/n]</td><td>0.259</td><td>0.486</td><td>0.139</td><td>1.... |
fef4c3de1c30af724f279d0110676e2059f453969e18fa90ebc35582352ac69e.png | simple | <table><tr><td></td><td>Effect</td><td>β</td><td>SE</td><td>P-Value</td></tr><tr><td>MVPA</td><td>Intercept</td><td>3.233</td><td>0.397</td><td><0.001</td></tr><tr><td></td><td>Maturity Offset</td><td>−0.077</td><td>0.098</td><td>0.434</td></tr><tr><td></td><td>Maturity Offset* Maturity Offset</td><td>0.0... | <table><tr><td></td></tr><tr><td>MVPA</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>MVPA-</td></tr><tr><td>PM Weekday</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><t... | <table><tr><td>Effect</td><td>β</td><td>SE</td><td>P-Value</td></tr><tr><td>Intercept</td><td>3.233</td><td>0.397</td><td><0.001</td></tr><tr><td>Maturity Offset</td><td>−0.077</td><td>0.098</td><td>0.434</td></tr><tr><td>Maturity Offset* Maturity Offset</td><td>0.026</td><td>0.009</td><td>0.005</td></tr><tr><td>Sex (r... |
f1141fff0398cace5b51cbad4dff0b493b7394003740cdbb654d6c280254e19a.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Men (<i>n</i> = 416)</td><td colspan="3">Women (<i>n</i> = 538)</td><td colspan="3">Both sexes (<i>n</i> = 954)</td></tr><tr><td>Prevalence</td><td>95% CI</td><td>Cases/All</td><td>Prevalence</td><td>95% CI</td><td>Cases/All</td><td>Prevalence</td><td>95% CI</td><td>Cases... | <table><tr><td rowspan="2"></td><td colspan="3">Men (n = 416)</td><td colspan="3">Women (n = 538)</td><td colspan="3">Both sexes (n = 954)</td></tr><tr><td>Prevalence</td><td>95% CI</td><td>Cases/All</td><td>Prevalence</td><td>95% CI</td><td>Cases/All</td><td>Prevalence</td><td>95% CI</td><td>Cases/All</td></tr><tr><td... | <table><tr><td>Awareness among all cases of HC</td><td>56.0%</td><td>45.1–66.8</td><td>47/84</td><td>72.5%</td><td>65.2–79.7</td><td>108/149</td><td>66.5%</td><td>60.4–72.6</td><td>155/233</td></tr><tr><td>Treatment among all cases of HC</td><td>36.9%</td><td>26.4–47.4</td><td>31/84</td><td>49.7%</td><td>41.5–57.8</td>... |
b7b5cec861783d22501c1d916276276aaa878abca51be4e16677c94b9f61e7aa.png | simple | <table><tr><td>Run (session)</td><td>Total Samples</td><td>Average Strokes per Minute (SPM)</td><td>Number of Observation slices</td><td>Type of run</td></tr><tr><td><i>A</i></td><td>6,500</td><td>33.4</td><td>13</td><td>inner-club competition</td></tr><tr><td><i>B</i></td><td>8,000</td><td>15.4</td><td>8</td><td>train... | <table><tr><td>Run (session)</td><td>Total Samples</td><td>Average Strokes per Minute (SPM)</td><td>Number of Observation slices</td></tr><tr><td>A</td><td>6,500</td><td>33.4</td><td>13</td></tr><tr><td>B</td><td>8,000</td><td>15.4</td><td>8</td></tr><tr><td>C</td><td>4,500</td><td>32.0</td><td>9</td></tr><tr><td>D</td... | <table><tr><td>Type of run</td></tr><tr><td>inner-club competition</td></tr><tr><td>training</td></tr><tr><td>inner-club competition</td></tr><tr><td>inner-club competition</td></tr><tr><td>recovery</td></tr></table> |
9f000eecdeb617d0725e9772ebd40c5fca110b5d3dfcb545a0cdc21579d99730.png | simple | <table><tr><td> </td><td> </td><td>AUC (95% CI)</td><td>Fold change<sup><i>∗</i></sup></td><td><i>P</i></td></tr><tr><td>ANC, 10<sup>3</sup>/<i>μ</i>L</td><td> </td><td>0.6001 (0.5689–0.6313)</td><td>—</td><td>—</td></tr><tr><td>FBG, mmol/L</td><td> </td><td>0.5876 (0.5561–0.6191)</td... | <table><tr><td></td><td></td><td>AUC (95% CI)</td><td>Fold change∗</td><td>P</td></tr><tr><td>ANC, 103/μL</td><td></td><td>0.6001 (0.5689–0.6313)</td><td>—</td><td>—</td></tr></table> | <table><tr><td></td><td></td><td>AUC (95% CI)</td><td>Fold change∗</td><td>P</td></tr><tr><td>FBG, mmol/L</td><td></td><td>0.5876 (0.5561–0.6191)</td><td>—</td><td>—</td></tr><tr><td>SCr, μmol/L</td><td></td><td>0.5545 (0.5225–0.5869)</td><td>—</td><td>—</td></tr><tr><td>SBP, mmHg</td><td></td><td>0.5767 (0.5457–0.6077... |
6fab6fd968367b17cea7baecb983e8df1fa567d19ba000ea825ffdfd2ded2132.png | complex | <table><tr><td colspan="3">DerSimonian and Laird results</td><td colspan="3"><i>Calculations for Hartung-Knapp-Sidik Jonkman</i></td></tr><tr><td>Study</td><td>Study results HR y<sub>i</sub></td><td>Weights w<sub>i</sub></td><td><i>ln(y</i><sub><i>i</i></sub><i>)</i></td><td><i>(ln(y</i><sub><i>i </i></sub><i>)–l... | <table><tr><td>DerSimonian and Laird results</td></tr><tr><td>Study</td></tr><tr><td>Cornelissen 2009</td></tr><tr><td>De Witte 1994</td></tr><tr><td>Fielding 2009</td></tr><tr><td>Goldstone 2008</td></tr><tr><td>Hunault 2004</td></tr><tr><td>Labar 2004</td></tr><tr><td>Ribera 2005</td></tr><tr><td>Sebban 1994</td></tr... | <table><tr><td colspan="2">DerSimonian and Laird results</td><td colspan="3">Calculations for Hartung-Knapp-Sidik Jonkman</td></tr><tr><td>Study results HR yi</td><td>Weights wi</td><td>ln(yi)</td><td>(ln(yi )–ln(y))2</td><td>wi×(ln(yi )–ln(y))2</td></tr><tr><td>0.81</td><td>5.0</td><td>−0.21</td><td>0.00</td><td>0.02<... |
6361c0f2e3f7922f16814fdde0aa2d4f98ff073f82793e41df6592124855d4f9.png | simple | <table><tr><td>Characteristics</td><td>Mean (SD); n (%)</td><td>Range:</td></tr><tr><td>Age in years</td><td>77.7 (5.89)</td><td>66-90</td></tr><tr><td>Women</td><td>25 (45.5%)</td><td>N/A</td></tr><tr><td>At least 1 fall in last 12 months</td><td>14 (25%)</td><td>N/A</td></tr><tr><td>BMI</td><td>25.8 (4.4)</td><td>14-... | <table><tr><td>Characteristics</td></tr><tr><td>Age in years</td></tr><tr><td>Women</td></tr><tr><td>At least 1 fall in last 12 months</td></tr><tr><td>BMI</td></tr><tr><td>Years of education</td></tr><tr><td>Cognition</td></tr><tr><td>MMSE Score (0-30)</td></tr><tr><td>MoCA score</td></tr><tr><td>Letter Number Sequenc... | <table><tr><td>Mean (SD); n (%)</td><td>Range:</td></tr><tr><td>77.7 (5.89)</td><td>66-90</td></tr><tr><td>25 (45.5%)</td><td>N/A</td></tr><tr><td>14 (25%)</td><td>N/A</td></tr><tr><td>25.8 (4.4)</td><td>14-42</td></tr><tr><td>12.1 (3.4)</td><td>(8-20)</td></tr><tr><td></td><td></td></tr><tr><td>26.8 (2.1)</td><td>21-3... |
11b699f27c5f4baf479879b66557c2c532d0e6eaf9330cf64e0b698ca4200e26.png | complex | <table><tr><td>RSSI location</td><td>SVD imaging biomarker</td><td>Frequency [i.e., number of patients (%)]</td><td>Median volume or score (IQR)</td><td>% [median (IQR)] of total ICV</td></tr><tr><td rowspan="9">Total brain</td><td>RSSI</td><td>187/187 (100)</td><td>0.75 (0.84) ml</td><td>0.05 (0.06)</td></tr><tr><td>W... | <table><tr><td>RSSI location</td><td>SVD imaging biomarker</td><td>Frequency [i.e., number of patients (%)]</td><td>Median volume or score (IQR)</td><td>% [median (IQR)] of total ICV</td></tr><tr><td rowspan="9">Total brain</td><td>RSSI</td><td>187/187 (100)</td><td>0.75 (0.84) ml</td><td>0.05 (0.06)</td></tr><tr><td>W... | <table><tr><td>RSSI location</td><td>SVD imaging biomarker</td><td>Frequency [i.e., number of patients (%)]</td><td>Median volume or score (IQR)</td><td>% [median (IQR)] of total ICV</td></tr><tr><td rowspan="7">Cerebellum/ brainstem</td><td>WMH</td><td>7/7 (100)</td><td>19.69 (16.66) ml</td><td>1.27 (1.19)</td></tr><t... |
ad9474519e5fc99599e65bca1f541b668af8d7fd28cb29448e57282da63357d1.png | simple | <table><tr><td>Name</td><td>Sel</td><td>Rec</td><td>VRec</td><td>VarN</td><td>M</td><td>MM</td><td>CEM</td><td>Seq</td><td>Tree</td><td>Ref</td></tr><tr><td>FPG</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>No</td><td>JH</td></tr><tr><td>EasyPop</td><td>No</td><td>Y... | <table><tr><td>Name</td><td>Sel</td><td>Rec</td><td>VRec</td><td>VarN</td><td>M</td><td>MM</td><td>CEM</td><td>Seq</td><td>Tree</td><td>Ref</td></tr></table> | <table><tr><td>FPG</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>No</td><td>JH</td></tr><tr><td>EasyPop</td><td>No</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>B01</td></tr><tr><td>SimuPop</td><td>Yes</td><td>Ye... |
a17f7f6ab2f36b64e20c4c8699b4598504d3ac1c6abc2b10f2f2ccbee8ad224d.png | complex | <table><tr><td>Variable</td><td>Number of workers</td><td>Cases</td><td>LBP (%)</td><td>χ<sup>2</sup></td><td><i>P</i></td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>< 25</td><td>48</td><td>41</td><td>85.4</td><td rowspan="3">0.839</td><td rowspan="3">0.657</td></tr><tr><td> ... | <table><tr><td>Variable</td><td>Number of workers</td><td>Cases</td><td>LBP (%)</td><td>χ2</td><td>P</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>< 25</td><td>48</td><td>41</td><td>85.4</td><td rowspan="3">0.839</td><td rowspan="3">0.657</td></tr><tr><td>25~</td><td>90</td><td>81</... | <table><tr><td>Physical exercise</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>yes</td><td>38</td><td>34</td><td>89.5</td><td rowspan="2">0.027</td><td rowspan="2">1.000</td></tr><tr><td>no</td><td>113</td><td>100</td><td>88.5</td></tr><tr><td>Smoking</td><td></td><td></td><td></td><td></td><td></td></t... |
becc62a63955c52d0f6914fd1c8c090ef86f450d0a6e3371ba13655e1a441750.png | complex | <table><tr><td rowspan="3"> </td><td colspan="5">Educational levels</td></tr><tr><td>Junior high school</td><td>High school</td><td>Junior or career college</td><td>University or higher education</td><td><i>P</i> for trend</td></tr><tr><td>Men</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Number o... | <table><tr><td rowspan="3"></td><td colspan="3">Educational levels</td></tr><tr><td>Junior high school</td><td>High school</td><td>Junior or career college</td></tr><tr><td colspan="3"></td></tr><tr><td>Men</td><td></td><td></td><td></td></tr><tr><td>Number of subjects</td><td>10 350</td><td>8437</td><td>1074</td></tr>... | <table><tr><td colspan="2">Educational levels</td></tr><tr><td>University or higher education</td><td>P for trend</td></tr><tr><td colspan="2"></td></tr><tr><td></td><td></td></tr><tr><td>1968</td><td></td></tr><tr><td>46.7</td><td><0.001</td></tr><tr><td>2.3</td><td><0.001</td></tr><tr><td>65.9</td><td>0.006</td></tr>... |
a96722b77b47b42248d6af7e2b566eed1f0175a928a4f02261704af3cb47fc59.png | complex | <table><tr><td>Participant characteristics</td><td>N (%)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td> Men</td><td>1 (6)</td></tr><tr><td> Women</td><td>16 (94)</td></tr><tr><td>Mean age (years)</td><td>38 (range 30–47)</td></tr><tr><td>Mean age of allergic children (years)</td><td>3 (range 0.5-10)</td></... | <table><tr><td>Participant characteristics</td><td>N (%)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td>Men</td><td>1 (6)</td></tr><tr><td>Women</td><td>16 (94)</td></tr><tr><td>Mean age (years)</td><td>38 (range 30–47)</td></tr><tr><td>Mean age of allergic children (years)</td><td>3 (range 0.5-10)</td></tr><tr><... | <table><tr><td>Fish</td><td>2 (12)</td></tr></table> |
9a475df7b52c4af61baf53714780093a1bf1a02d336f8fc023a4f9b983dfcaf0.png | complex | <table><tr><td colspan="6">IC<sub>50</sub> (ng mL<sup>−1</sup>): median (values obtained with two independent experiments)</td></tr><tr><td></td><td>Fraction Weight (%)</td><td>Distribution of PnTX-G (%)</td><td>KB cells (72 h of incubation)</td><td>Neuro2A cells (24 h of incubation)</td><td>Undifferentiated Caco... | <table><tr><td colspan="6">IC50 (ng mL−1): median (values obtained with two independent experiments)</td></tr><tr><td></td><td>Fraction Weight (%)</td><td>Distribution of PnTX-G (%)</td><td>KB cells (72 h of incubation)</td><td>Neuro2A cells (24 h of incubation)</td><td>Undifferentiated Caco-2 cells (48 h of incubation... | <table><tr><td colspan="6">IC50 (ng mL−1): median (values obtained with two independent experiments)</td></tr><tr><td>F3</td><td>26.5</td><td>100</td><td>2.59 (2.55, 2.63)</td><td>25 (44–6)</td><td>N.R. (42.6%)</td></tr><tr><td>F4</td><td>4.6</td><td>0</td><td>53.6 (45.4, 61.8)</td><td>575 (760–390)</td><td>N.R. (25.2%... |
9c1af9f2aa603d0f6159a93e2d758b8cc7bcc773d452517deaf571b5b90d5de9.png | simple | <table><tr><td>Question</td><td>Percent of responses correct (2011–2012)</td><td>Percent of responses correct (2012–2013)</td><td>Percent of responses correct (2013–2014)</td></tr><tr><td>There is no cure for asthma</td><td>80.8</td><td>84.9</td><td>90.3</td></tr><tr><td>Although asthma causes breathi... | <table><tr><td>Question</td><td>Percent of responses correct (2011–2012)</td><td>Percent of responses correct (2012–2013)</td><td>Percent of responses correct (2013–2014)</td></tr><tr><td>There is no cure for asthma</td><td>80.8</td><td>84.9</td><td>90.3</td></tr><tr><td>Although asthma causes breathing problems, asthm... | <table><tr><td>Question</td><td>Percent of responses correct (2011–2012)</td><td>Percent of responses correct (2012–2013)</td><td>Percent of responses correct (2013–2014)</td></tr><tr><td>A person should take steroids for asthma to grow muscle mass for better athletic ability</td><td>86.8</td><td>89.7</td><td>91.2</td>... |
8ac62725676875d146781f5694f83393e79ede61b5c675dcd039d51d862cad34.png | complex | <table><tr><td></td><td>No decrease in haemoglobin, <i>n</i> (%)</td><td>With a decrease in haemoglobin, <i>n</i> (%)</td></tr><tr><td>Celecoxib <i>N</i> = 872</td><td>841 (96.44)</td><td>31 (3.56)</td></tr><tr><td>Diclofenac <i>N</i> = 438</td><td>412 (94.06)</td><td>26 (5.94)</td></tr><tr><td></td><td colspan="2">OR ... | <table><tr><td></td><td>No decrease in haemoglobin, n (%)</td></tr><tr><td>Celecoxib N = 872</td><td>841 (96.44)</td></tr><tr><td>Diclofenac N = 438</td><td>412 (94.06)</td></tr><tr><td></td><td>OR = 1.71 (1.00–2.92)</td></tr></table> | <table><tr><td>With a decrease in haemoglobin, n (%)</td></tr><tr><td>31 (3.56)</td></tr><tr><td>26 (5.94)</td></tr><tr><td>OR = 1.71 (1.00–2.92)</td></tr></table> |
ef6f1d8ea4e4a8799a44495d81a4ebb3f4372996612b5974e691bc4b78ebeab0.png | complex | <table><tr><td> </td><td colspan="2">NTM lung diseases patients (N = 84)</td><td colspan="2">Non-NTM BE patients (N = 47)</td><td><i>P </i>value</td></tr><tr><td>Any isolates</td><td>17 </td><td>(20.2%)</td><td>12 </td><td>(25.5%)</td><td>1.00</td></tr><tr><td>Single isolate in one patient</td><td>15 </td><td>(19.7%)</... | <table><tr><td></td><td colspan="2">NTM lung diseases patients (N = 84)</td><td colspan="2">Non-NTM BE patients (N = 47)</td><td>P value</td></tr><tr><td>Any isolates</td><td>17</td><td>(20.2%)</td><td>12</td><td>(25.5%)</td><td>1.00</td></tr><tr><td>Single isolate in one patient</td><td>15</td><td>(19.7%)</td><td>12</... | <table><tr><td></td><td colspan="2">NTM lung diseases patients (N = 84)</td><td>Non-NTM BE patients (N = 47)</td><td>P value</td></tr><tr><td>Any isolates</td><td>17</td><td>(20.2%)</td><td>12</td><td>1.00</td></tr><tr><td>Multiple microorganisms</td><td>2</td><td>(2.4%)</td><td>0</td><td>0.54</td></tr><tr><td>Methicil... |
31cfdfacad74050631aa36354b7df556aa9250907c0a2a553374a60fda6f1ba8.png | complex | <table><tr><td>Disease condition</td><td colspan="2">No (<i>n</i>, %)</td><td colspan="2">Somewhat (<i>n</i>, %)</td><td colspan="2">Yes (<i>n</i>, %)</td></tr><tr><td>Endocrine disorders (diabetes mellitus, thyroid disease)</td><td>81</td><td>36.7 %</td><td>65</td><td>29.4 %</td><td>75</td><td>33.9 %</td></tr><tr><td>... | <table><tr><td>Disease condition</td><td colspan="2">No (n, %)</td><td colspan="2">Somewhat (n, %)</td><td>Yes (n, %)</td></tr><tr><td>Endocrine disorders (diabetes mellitus, thyroid disease)</td><td>81</td><td>36.7 %</td><td>65</td><td>29.4 %</td><td>75</td></tr><tr><td>Acute coronary syndrome</td><td>3</td><td>1.4 %<... | <table><tr><td>Yes (n, %)</td></tr><tr><td>33.9 %</td></tr><tr><td>80.1 %</td></tr><tr><td>18.6 %</td></tr><tr><td>46.6 %</td></tr><tr><td>5.0 %</td></tr><tr><td>37.7 %</td></tr><tr><td>75.6 %</td></tr><tr><td>10.5 %</td></tr><tr><td>42.5 %</td></tr><tr><td>46.2 %</td></tr><tr><td>16.4 %</td></tr><tr><td>58.9 %</td></t... |
d2313a3e47fcefa7f94ec325273d14220c5d212a6c22550c98a68fb5deb84b94.png | simple | <table><tr><td></td><td>Explicit LearningGroup (n = 40)</td><td>Implicit Learning Group (n = 40)</td><td>ControlGroup (n = 40)</td></tr><tr><td>T1Intervention</td><td>30 side-step cutting trials -Detailed verbal instructions on performance will be given</td><td>30 side-step cutting trials - Best performance will be sho... | <table><tr><td></td><td>Explicit LearningGroup (n = 40)</td><td>Implicit Learning Group (n = 40)</td><td>ControlGroup (n = 40)</td></tr></table> | <table><tr><td>T1Intervention</td><td>30 side-step cutting trials -Detailed verbal instructions on performance will be given</td><td>30 side-step cutting trials - Best performance will be shown</td><td>30 side-step cutting trials -No feedback on performance will be given</td></tr><tr><td>T2Retention test (one week post... |
33f7f80d295bb41fab74787d0792e22fb3bddd17f70e072f8b41a347c8b0caeb.png | complex | <table><tr><td>Population/Gender (N)</td><td colspan="7">G6PD variant allele frequency</td></tr><tr><td></td><td>Mahidol</td><td>Viangchan</td><td>Chinese 4</td><td>Union</td><td>Canton</td><td>Kaiping</td><td>Gaohe</td></tr><tr><td>Thai</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ma... | <table><tr><td>Population/Gender (N)</td><td colspan="7">G6PD variant allele frequency</td></tr><tr><td></td><td>Mahidol</td><td>Viangchan</td><td>Chinese 4</td><td>Union</td><td>Canton</td><td>Kaiping</td><td>Gaohe</td></tr><tr><td>Thai</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Ma... | <table><tr><td>Population/Gender (N)</td><td colspan="7">G6PD variant allele frequency</td></tr><tr><td></td><td>Mahidol</td><td>Viangchan</td><td>Chinese 4</td><td>Union</td><td>Canton</td><td>Kaiping</td><td>Gaohe</td></tr><tr><td>Burmese</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td... |
c1a904d6c0069fde146e82a237f4d4b594619df61ef7c2b73f10a698631cc19a.png | simple | <table><tr><td>Models</td><td>BM</td><td>GM-A</td><td>GM-B</td><td>LRM-1</td><td>LRM-2</td></tr><tr><td>BM</td><td>100 % (46)</td><td>78 % (36)</td><td>74 % (34)</td><td>76 % (35)</td><td>76 % (35)</td></tr><tr><td>GM-A</td><td>.</td><td>100 % (46)</td><td>96 % (44)</td><td>87 % (40)</td><td>91 % (42)</td></tr><tr><td>... | <table><tr><td>Models</td><td>BM</td><td>GM-A</td><td>GM-B</td><td>LRM-1</td><td>LRM-2</td></tr><tr><td>BM</td><td>100 % (46)</td><td>78 % (36)</td><td>74 % (34)</td><td>76 % (35)</td><td>76 % (35)</td></tr><tr><td>GM-A</td><td>.</td><td>100 % (46)</td><td>96 % (44)</td><td>87 % (40)</td><td>91 % (42)</td></tr><tr><td>... | <table><tr><td>Models</td><td>BM</td><td>GM-A</td><td>GM-B</td><td>LRM-1</td><td>LRM-2</td></tr><tr><td>LRM-2</td><td>.</td><td>.</td><td>.</td><td>.</td><td>100 % (46)</td></tr></table> |
e9ef5d1fca18cbda8134cc90c1c9339787580ca96eb9bdf917b763b16981eb6b.png | simple | <table><tr><td>Demographic information</td><td>Patients</td></tr><tr><td>Sex Ratio</td><td>12 women and 7 men</td></tr><tr><td>Age (years)</td><td>56 ± 8.96</td></tr><tr><td>Height (cm)</td><td>164.52 ± 5.09</td></tr><tr><td>Weight (kg)</td><td>76.52 ± 12.87</td></tr><tr><td>BMI (Kg/m<sup>2</sup>)</td><t... | <table><tr><td>Demographic information</td><td>Patients</td></tr><tr><td>Sex Ratio</td><td>12 women and 7 men</td></tr><tr><td>Age (years)</td><td>56 ± 8.96</td></tr></table> | <table><tr><td>Height (cm)</td><td>164.52 ± 5.09</td></tr><tr><td>Weight (kg)</td><td>76.52 ± 12.87</td></tr><tr><td>BMI (Kg/m2)</td><td>28.33 ± 4.65</td></tr><tr><td>Diabetic History (years)</td><td>11.84 ± 6.93</td></tr></table> |
08661e8f83016a8ad1d000ca197a20bcf642af16fab6d164ea0db18ad3ec159b.png | complex | <table><tr><td></td><td><i>A. niger</i> DS03043</td><td><i>A. niger</i> CBS513.88</td></tr><tr><td colspan="3">A</td></tr><tr><td> μ (h<sup>−1</sup>)</td><td>0.14 ± 0.01</td><td>0.10 ± 0.01</td></tr><tr><td> q<sub>S</sub> (mmol/gDCW h)</td><td>1.83 ± 0.01</td><td>1.46 ± 0.01</td></tr><tr>... | <table><tr><td></td><td>A. niger DS03043</td><td>A. niger CBS513.88</td></tr><tr><td colspan="3">A</td></tr><tr><td>μ (h−1)</td><td>0.14 ± 0.01</td><td>0.10 ± 0.01</td></tr><tr><td>qS (mmol/g</td><td>1.83 ± 0.01</td><td>1.46 ± 0.</td></tr></table> | <table><tr><td></td><td>A. niger DS03043</td><td>A. niger CBS513.88</td></tr><tr><td>DCW h)</td><td></td><td>01</td></tr><tr><td>qGA (μmol/gDCW h)a</td><td>0.40 ± 0.03</td><td>0.05 ± 0.00</td></tr><tr><td>qCIT (mmol/gDCW h)</td><td>0.02 ± 0.00</td><td>0.11 ± 0.01</td></tr><tr><td>qOA (mmol/gDCW h)</td><td>0.11 ± 0.01</... |
a3bab1742c70aa981ca412e19fa98ce9bf468622499ef4975d4c2b2cd0f784d6.png | simple | <table><tr><td>Axillary vs. tympanic temperature</td><td>Correlation Coefficient</td><td>Bias ± SD</td><td>95% CI</td><td>Limits of agreement</td></tr><tr><td> </td><td>0.697</td><td>−0.093 ± 0.72</td><td>−0.20; 0.02</td><td>−1.54 to 1.36</td></tr></table> | <table><tr><td>Axillary vs. tympanic temperature</td></tr><tr><td></td></tr></table> | <table><tr><td>Correlation Coefficient</td><td>Bias ± SD</td><td>95% CI</td><td>Limits of agreement</td></tr><tr><td>0.697</td><td>−0.093 ± 0.72</td><td>−0.20; 0.02</td><td>−1.54 to 1.36</td></tr></table> |
a71bf353944f4b75210260f37f2fbef1bfc8278797999e067a25a6251e8ee037.png | simple | <table><tr><td></td><td>Carbon Monoxide (ppm)</td><td>CO StdDev (ppm)</td><td>Nicotine (mg/m3)</td><td>Gravimetric TSP (mg/m3)</td><td>TSP StdDev (mg/m3)</td></tr><tr><td>Day 1</td><td>157.73</td><td>11.04</td><td></td><td>41.31</td><td>2.29</td></tr><tr><td>Day 2</td><td>172.50</td><td>11.37</td><td></td><td>50.55</td... | <table><tr><td></td><td>Carbon Monoxide (ppm)</td></tr><tr><td>Day 1</td><td>157.73</td></tr><tr><td>Day 2</td><td>172.50</td></tr><tr><td>Day 3</td><td>217.27</td></tr><tr><td>Day 4</td><td>216.36</td></tr><tr><td>Day 5</td><td>230.91</td></tr><tr><td>Day 8</td><td>243.64</td></tr><tr><td>Day 9</td><td>240.00</td></tr... | <table><tr><td>CO StdDev (ppm)</td><td>Nicotine (mg/m3)</td><td>Gravimetric TSP (mg/m3)</td><td>TSP StdDev (mg/m3)</td></tr><tr><td>11.04</td><td></td><td>41.31</td><td>2.29</td></tr><tr><td>11.37</td><td></td><td>50.55</td><td>3.36</td></tr><tr><td>7.86</td><td>12.10</td><td>65.76</td><td>3.26</td></tr><tr><td>11.42</... |
4f319f889ea69f419f1328c6b0a0989f6cf731ee61a8fa6c0be27b2b92baeef4.png | complex | <table><tr><td></td><td colspan="4">Overall cohort</td><td colspan="4">PS-matched cohort</td></tr><tr><td></td><td>Group A</td><td>Group B</td><td>Difference Group B – Group A</td><td><i>p</i></td><td>Group A</td><td>Group B</td><td>Difference Group B – Group A</td><td><i>p</i></td></tr><tr><td>n. GP Visits... | <table><tr><td></td><td colspan="4">Overall cohort</td><td colspan="4">PS-matched cohort</td></tr><tr><td></td><td>Group A</td><td>Group B</td><td>Difference Group B – Group A</td><td>p</td><td>Group A</td><td>Group B</td><td>Difference Group B – Group A</td><td>p</td></tr><tr><td>n. GP Visits mean (±SE)</td><td>0.84 (... | <table><tr><td></td><td colspan="4">Overall cohort</td><td colspan="4">PS-matched cohort</td></tr><tr><td></td><td>Group A</td><td>Group B</td><td>Difference Group B – Group A</td><td>p</td><td>Group A</td><td>Group B</td><td>Difference Group B – Group A</td><td>p</td></tr><tr><td>Specialist visits mean (±SE)</td><td>0... |
76f1a84f8b9ac036cb667a5200b183a960d5b6d3b3ac84d120b0e4ae495e37d4.png | simple | <table><tr><td>Characteristics</td><td>Categories</td><td>Crude riskratios</td><td>95% confidence intervals</td><td>P-value</td></tr><tr><td>Women’s age (years)</td><td>13-19</td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>20-24 </td><td>0.96</td><td>0.33 - 2.79 </td><td>0.942</td></tr><tr><td></td><td>2... | <table><tr><td>Characteristics</td><td>Categories</td><td>Crude riskratios</td><td>95% confidence intervals</td><td>P-value</td></tr><tr><td>Women’s age (years)</td><td>13-19</td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>20-24</td><td>0.96</td><td>0.33 - 2.79</td><td>0.942</td></tr><tr><td></td><td>25-29</td... | <table><tr><td>verity of pre-eclampsia</td><td>ild</td><td></td><td></td><td></td></tr><tr><td></td><td>Severe</td><td>3.85</td><td>1.69 - 8.80</td><td>0.001</td></tr></table> |
dd918547dd608e187fa8299e08647f0c910f05bf43e10905213b1da0d7aa8d0c.png | simple | <table><tr><td><i>Isolate</i></td><td><i>Geographic origin</i></td><td><i>Year</i></td><td><i>Source</i>a</td><td><i>Alternative ID</i></td><td><i>GenBank/ EBI accession number</i></td></tr><tr><td>Rs 10</td><td>New Brunswick, Canada</td><td>2009</td><td><i>Salmo salar</i> (sw)</td><td> </td><td>ERR327945</td></tr><tr>... | <table><tr><td>Isolate</td><td>Geographic origin</td><td>Year</td><td>Sourcea</td></tr><tr><td>Rs 10</td><td>New Brunswick, Canada</td><td>2009</td><td>Salmo salar (sw)</td></tr><tr><td>Rs 2</td><td>New Brunswick, Canada</td><td>2005</td><td>S. salar (sw)</td></tr><tr><td>Rs 3</td><td>New Brunswick, Canada</td><td>2005... | <table><tr><td>Alternative ID</td><td>GenBank/ EBI accession number</td></tr><tr><td></td><td>ERR327945</td></tr><tr><td></td><td>ERR327951</td></tr><tr><td></td><td>ERR327947</td></tr><tr><td></td><td>ERR327946</td></tr><tr><td></td><td>ERR327950</td></tr><tr><td></td><td>ERR327953</td></tr><tr><td></td><td>ERR327944<... |
e739e8d18558dbe8e0ea74df4740246c44a4125df6f88d15a6cde2ddc25a0dcf.png | complex | <table><tr><td>Location, study period (reference)</td><td>PM size</td><td>Type of fuel</td><td>Mean (μg/m<sup>3</sup>)</td><td>Notes</td></tr><tr><td colspan="5">China</td></tr><tr><td>Shenyang, China, May 2006 (this study)</td><td>PM<sub>10</sub></td><td>Crop residue</td><td>Total: 100.6Cooking times: 202.1</td><... | <table><tr><td>Location, study period (reference)</td><td>PM size</td><td>Type of fuel</td><td>Mean (μg/m3)</td><td>Notes</td></tr><tr><td colspan="5">China</td></tr><tr><td>Shenyang, China, May 2006 (this study)</td><td>PM10</td><td>Crop residue</td><td>Total: 100.6Cooking times: 202.1</td><td>Based on ~14 hr/day (053... | <table><tr><td>Location, study period (reference)</td><td>PM size</td><td>Type of fuel</td><td>Mean (μg/m3)</td><td>Notes</td></tr><tr><td>Cantuyo, Jan 1994–Oct 1995 (Albalak et al. 1999)</td><td>PM10</td><td>Dung</td><td>1,830</td><td>Based on 6-hr periods (0500–1100)/day every 6 days for 3 consecutive weeks for each ... |
97b7dd1c7bdc7450a50bbe67e2ec3fe1a9cc7a22fc51e355abf27e0d5193cb6e.png | simple | <table><tr><td></td><td>Coefficient</td><td>Standard error</td><td><i>P</i></td><td>Adjusted <i>R</i><sup>2</sup></td></tr><tr><td><i>Overall survival</i></td><td></td><td></td><td></td><td></td></tr><tr><td>Sampling time</td><td>0.2797</td><td>0.1995</td><td>0.18</td><td>4.16%</td></tr><tr><td>Metastatic status</td><t... | <table><tr><td></td><td>Coefficient</td><td>Standard error</td><td>P</td><td>Adjusted R2</td></tr><tr><td>Overall survival</td><td></td><td></td><td></td><td></td></tr><tr><td>Sampling time</td><td>0.2797</td><td>0.1995</td><td>0.18</td><td>4.16%</td></tr><tr><td>Metastatic status</td><td>−0.0362</td><td>0.1089</td><td... | <table><tr><td></td><td>Coefficient</td><td>Standard error</td><td>P</td><td>Adjusted R2</td></tr><tr><td>Country</td><td>0.0277</td><td>0.1945</td><td>0.889</td><td>−11.56%</td></tr><tr><td>Study quality</td><td>−0.0316</td><td>0.1196</td><td>0.795</td><td>−9.52%</td></tr><tr><td>Disease-free survival</td><td></td><td... |
c9f3ec337d6d462051b81c9950848e0c3142b65ab3f1706946a1b521c4781ec2.png | simple | <table><tr><td>Orifices</td><td>n right</td><td>% right</td><td>n left</td><td>% left</td></tr><tr><td>1</td><td>7</td><td>7.2</td><td>6</td><td>6.3</td></tr><tr><td>2</td><td>8</td><td>8.2</td><td>17</td><td>17.7</td></tr><tr><td>3</td><td>28</td><td>28.9</td><td>21</td><td>21.9</td></tr><tr><td>4</td><td>22</td><td>2... | <table><tr><td>Orifices</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>7</td></tr><tr><td>8</td></tr><tr><td>sum</td></tr></table> | <table><tr><td>n right</td><td>% right</td><td>n left</td><td>% left</td></tr><tr><td>7</td><td>7.2</td><td>6</td><td>6.3</td></tr><tr><td>8</td><td>8.2</td><td>17</td><td>17.7</td></tr><tr><td>28</td><td>28.9</td><td>21</td><td>21.9</td></tr><tr><td>22</td><td>22.7</td><td>21</td><td>21.9</td></tr><tr><td>17</td><td>1... |
806d5d40aa69b27bf562012d2bd2687b3721e956e45fa0d6267b25e82ab58e21.png | simple | <table><tr><td>AGI</td><td>Annotation</td><td><i>P</i>-score</td><td>References</td></tr><tr><td>AT2G30870</td><td>ERD13, glutathione-<i>S</i>-transferase PHI 10</td><td>32</td><td>Ryu <i>et al.</i> (2009), Carter <i>et al.</i> (2004) and Marmagne <i>et al.</i> (2007)</td></tr><tr><td>AT2G45820*</td><td>Remorin, putati... | <table><tr><td>AGI</td><td>Annotation</td><td>P-score</td><td>References</td></tr><tr><td>AT2G30870</td><td>ERD13, glutathione-S-transferase PHI 10</td><td>32</td><td>Ryu et al. (2009), Carter et al. (2004) and Marmagne et al. (2007)</td></tr><tr><td>AT2G45820*</td><td>Remorin, putative DNA-binding protein, salt-induce... | <table><tr><td>AGI</td><td>Annotation</td><td>P-score</td></tr><tr><td>AT3G15260*</td><td>PP2C, protein phosphatase 2C family, group F</td><td>4</td></tr></table> |
144da4c86763e0033b0c3d9f0f0c0b90840673f2be5cc07449d030d76f28012c.png | complex | <table><tr><td>VARIABLE, n (%)</td><td>MAIN SAMPLE (<i>N</i> = 10283)</td><td>SUBSAMPLE (<i>N</i> = 496)</td></tr><tr><td>Age, mean (Years)</td><td>61.7<sup>a b</sup></td><td>69 <sup>c d</sup></td></tr><tr><td colspan="3">Gender</td></tr><tr><td> Male</td><td>3333 (32)</td><td>181 (37)</td></tr><tr><td> Female</td><td>... | <table><tr><td>VARIABLE, n (%)</td></tr><tr><td>Age, mean (Years)</td></tr><tr><td>Gender</td></tr><tr><td>Male</td></tr><tr><td>Female</td></tr><tr><td>Race</td></tr><tr><td>Blacks</td></tr><tr><td>Whites</td></tr><tr><td>Education</td></tr><tr><td>≤ High or trade</td></tr><tr><td>Some College</td></tr><tr><td>College... | <table><tr><td>MAIN SAMPLE (N = 10283)</td><td>SUBSAMPLE (N = 496)</td></tr><tr><td>61.7a b</td><td>69 c d</td></tr><tr><td colspan="2">Gender</td></tr><tr><td>3333 (32)</td><td>181 (37)</td></tr><tr><td>6946 (68)</td><td>312 (63)</td></tr><tr><td colspan="2">Race</td></tr><tr><td>3750 (36)</td><td>192 (41)</td></tr><t... |
8fc36b82584ddfdc1f14229ba8baaab046598dffc7317210b51fd2923e8abad2.png | complex | <table><tr><td>Variable</td><td>OR</td><td><i>p</i></td><td>95% conf. interval</td></tr><tr><td colspan="4">Received blood transfusion</td></tr><tr><td>Age</td><td>1.12</td><td><0.01</td><td>1.06–1.19</td></tr><tr><td>Sex</td><td>1.35</td><td>0.32</td><td>0.74–2.46</td></tr><tr><td>Bilirubin</td><td>0.81... | <table><tr><td>Variable</td><td>OR</td><td>p</td><td>95% conf. interval</td></tr><tr><td colspan="4">Received blood transfusion</td></tr><tr><td>Age</td><td>1.12</td><td><0.01</td><td>1.06–1.19</td></tr><tr><td>Sex</td><td>1.35</td><td>0.32</td><td>0.74–2.46</td></tr><tr><td>Bilirubin</td><td>0.81</td><td>0.01</td><td>... | <table><tr><td>Age</td><td>1.01</td><td>0.85</td><td>0.94–1.07</td></tr><tr><td>Sex</td><td>1.80</td><td>0.06</td><td>0.98–3.29</td></tr><tr><td>Bilirubin</td><td>0.86</td><td>0.20</td><td>0.69–1.08</td></tr></table> |
0a3cc3c52a8c5ce9b4434cb04b2f8a1bbf03df392d838641c5fc5158c9d0c5b1.png | simple | <table><tr><td></td><td>Placebo(n = 6)</td><td>Ascorbic acid(n = 5)</td></tr><tr><td>Male/Female (numbers)</td><td>2/4</td><td>3/2</td></tr><tr><td>Age (years)<sup>b</sup></td><td>16 (13-24)</td><td>19 (14-24)</td></tr><tr><td>Median nerve MNCV (m/s)<sup>a</sup></td><td>17.9 (6.0)</td><td>17.2 (1.7)</td></tr><tr><td>Me... | <table><tr><td></td><td>Placebo(n = 6)</td></tr><tr><td>Male/Female (numbers)</td><td>2/4</td></tr><tr><td>Age (years)b</td><td>16 (13-24)</td></tr><tr><td>Median nerve MNCV (m/s)a</td><td>17.9 (6.0)</td></tr><tr><td>Median nerve minimal F response latency (ms)a</td><td>83.8 (28.0)*</td></tr><tr><td>CMAP amplitude abdu... | <table><tr><td>Ascorbic acid(n = 5)</td></tr><tr><td>3/2</td></tr><tr><td>19 (14-24)</td></tr><tr><td>17.2 (1.7)</td></tr><tr><td>77.1 (10.6)</td></tr><tr><td>4.0 (1.2)</td></tr><tr><td>73.8 (24.7)</td></tr><tr><td>91.1 (26.9)</td></tr><tr><td>3 (1-6)</td></tr><tr><td>13 (7-17)</td></tr><tr><td>2 (2-4)</td></tr><tr><td... |
add85c7fbc26597ad2b766979a288af71fa93dbe90d47f22a4bf99bcbfaf5f45.png | complex | <table><tr><td>RT inhibitors</td><td colspan="2">EC<sub>50 </sub>(nM)<sup>a</sup></td></tr><tr><td></td><td>Subtype B HIV-1</td><td>Subtype C HIV-1</td></tr><tr><td>ZDV</td><td>12.9 ± 5.9</td><td>34.8 ± 12.9</td></tr><tr><td>3TC</td><td>45.4 ± 16.4</td><td>105.9 ± 40.2</td></tr><tr><td>TFV</td><td>3... | <table><tr><td>RT inhibitors</td><td>EC50 (nM)a</td></tr><tr><td></td><td>Subtype B HIV-1</td></tr><tr><td>ZDV</td><td>12.9 ± 5.9</td></tr><tr><td>3TC</td><td>45.4 ± 16.4</td></tr><tr><td>TFV</td><td>334.8 ± 140.9</td></tr><tr><td>NVP</td><td>50.2 ± 29.6</td></tr><tr><td>EFV</td><td>0.6 ± 0.2</td></tr><tr><td>ETR</td><... | <table><tr><td>EC50 (nM)a</td></tr><tr><td>Subtype C HIV-1</td></tr><tr><td>34.8 ± 12.9</td></tr><tr><td>105.9 ± 40.2</td></tr><tr><td>304.8 ± 93.1</td></tr><tr><td>170.4 ± 79.5</td></tr><tr><td>1.3 ± 0.4</td></tr><tr><td>0.5 ± 0.01</td></tr></table> |
c21536e04dd47fa6b0df15059f834f733c11d3246bc415b357b8c04c29d9b17d.png | complex | <table><tr><td></td><td colspan="2">Ibague(n = 855)</td><td colspan="2">Rural area(n = 1,556)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>293</td><td>34.4</td><td>487</td><td>31.4</td></tr><tr><td>Female</td><td>559</td... | <table><tr><td></td><td colspan="2">Ibague(n = 855)</td><td colspan="2">Rural area(n = 1,556)</td></tr></table> | <table><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>293</td><td>34.4</td><td>487</td><td>31.4</td></tr><tr><td>Female</td><td>559</td><td>65.6</td><td>1,065</td><td>68.6</td></tr><tr><td>Age group</td><td></td><td></td><td></td><... |
04cf828359c53998f1fcaeeaa4081b495f3676dbced9010d74392359be36f824.png | complex | <table><tr><td rowspan="2">Treatment</td><td colspan="2">Vehicle control</td><td colspan="2">Positive control MMC(0.20 <i>μ</i>g/mL)</td><td colspan="2">NR-INF-02(2500.00 <i>μ</i>g/mL)</td><td colspan="2">NR-INF-02(791.14 <i>μ</i>g/mL)</td><td colspan="2">NR-INF-02(250.36 <i>μ</i>g/mL)</td></tr><tr>... | <table><tr><td rowspan="2">Treatment</td><td colspan="2">Vehicle control</td><td colspan="2">Positive control MMC(0.20 μg/mL)</td><td colspan="2">NR-INF-02(2500.00 μg/mL)</td><td colspan="2">NR-INF-02(791.14 μg/mL)</td><td colspan="2">NR-INF-02(250.36 μg/mL)</td></tr><tr><td>R1</td><td>R2</td><td>R1</td><td>R2</td><td>... | <table><tr><td rowspan="2">Treatment</td><td colspan="2">Vehicle control</td><td colspan="2">Positive control MMC(0.20 μg/mL)</td><td colspan="2">NR-INF-02(2500.00 μg/mL)</td><td colspan="2">NR-INF-02(791.14 μg/mL)</td><td colspan="2">NR-INF-02(250.36 μg/mL)</td></tr><tr><td>R1</td><td>R2</td><td>R1</td><td>R2</td><td>... |
39f07ddf1072265f772e3bd78a8da302a424739919ff8df6cda6d449f3ebfe6e.png | complex | <table><tr><td rowspan="2">Sample ID</td><td colspan="10">Estimated Daily Intakes (EDI)</td></tr><tr><td>Al</td><td>Mn</td><td>Pb</td><td>Cd</td><td>Hg</td><td>As</td><td>Cr</td><td>Ni</td><td>Cu</td><td>Zn</td></tr><tr><td>PNY1</td><td>9.60 × 10<sup>−3</sup></td><td>8.09 × 10<sup>−3</sup></td><td... | <table><tr><td rowspan="2">Sample ID</td><td colspan="10">Estimated Daily Intakes (EDI)</td></tr><tr><td>Al</td><td>Mn</td><td>Pb</td><td>Cd</td><td>Hg</td><td>As</td><td>Cr</td><td>Ni</td><td>Cu</td><td>Zn</td></tr><tr><td>PNY1</td><td>9.60 × 10−3</td><td>8.09 × 10−3</td><td>8.80 × 10−6</td><td>5.64 × 10−7</td><td>5.3... | <table><tr><td>10</td><td>−2</td><td>08 × 10−2</td><td>−6</td><td>64 × 10−7</td><td>× 10−6</td><td>−6</td><td>9 × 10−5</td><td>99 × 10−4</td><td>12 × 10−4</td><td>10−3</td></tr><tr><td>PNY11</td><td>1.34 × 10−2</td><td>3.39 × 10−2</td><td>7.22 × 10−6</td><td>3.76 × 10−7</td><td>3.01 × 10−6</td><td>4.71 × 10−6</td><td>4... |
caa48295a9b0b7b852963cb4970add762dbb21997f2d4ca2e61ed734515883ff.png | simple | <table><tr><td>Protein Name</td><td>Uniprot ID</td><td>Function</td><td>Up- or downregulated<sup>a</sup></td></tr><tr><td>DNA-dependent protein kinase catalytic subunit</td><td>P78527</td><td>Serine/threonine-protein kinase, molecular sensor for DNA damage.</td><td>Up</td></tr><tr><td>Lumican</td><td>P51884</td><td>Col... | <table><tr><td>Protein Name</td></tr><tr><td>DNA-dependent protein kinase catalytic subunit</td></tr><tr><td>Lumican</td></tr><tr><td>Tetranectin</td></tr><tr><td>Gelsolin</td></tr><tr><td>Cartilage acidic protein 1</td></tr><tr><td>Matrin-3</td></tr><tr><td>Glucose-6-phosphate isomerase</td></tr><tr><td>Coactosin-like... | <table><tr><td>Uniprot ID</td><td>Function</td><td>Up- or downregulateda</td></tr><tr><td>P78527</td><td>Serine/threonine-protein kinase, molecular sensor for DNA damage.</td><td>Up</td></tr><tr><td>P51884</td><td>Collagen fibril organization, epithelial cell migration and tissue repair.</td><td>Down</td></tr><tr><td>P... |
67ae8c0f32a149652914751f02a84301ba18413eeab6a7a272bc1d81cea7e55d.png | simple | <table><tr><td> </td><td>Group P (<i>n</i> = 13)</td><td>Group R(<i>n</i> = 28)</td><td><i>P</i> value</td></tr><tr><td>Mean decrease in Hb<sup>†</sup> (g/dL ± SD<sup>‡</sup>)</td><td>0.21 ± 0.66</td><td>0.37 ± 0.67</td><td>0.55</td></tr><tr><td>Mean procedure time (min ± SD)</td><td>87.... | <table><tr><td></td><td>Group P (n = 13)</td><td>Group R(n = 28)</td><td>P value</td></tr><tr><td>Mean decrease in Hb† (g/dL ± SD‡)</td><td>0.21 ± 0.66</td><td>0.37 ± 0.67</td><td>0.55</td></tr><tr><td>Mean procedure time (min ± SD)</td><td>87.5 ± 51.3</td><td>99.5 ± 46.1</td><td>0.28</td></tr><tr><td>Incidence of perf... | <table><tr><td></td><td>Group P (n = 13)</td><td>Group R(n = 28)</td><td>P value</td></tr><tr><td>Incidence of muscle injury, % (n)</td><td>15.4 (2)</td><td>28.6 (8)</td><td>0.36</td></tr><tr><td>Incidence of postoperative fever, % (n)</td><td>7.7 (1)</td><td>10.7 (3)</td><td>0.76</td></tr><tr><td>Incidence of postoper... |
fa879fccab71bf44e9f4c02bf748930fd6c65534d44f30a9a22a9d4a58f35a72.png | complex | <table><tr><td rowspan="2">Material</td><td>Thermal conductivity</td><td>Specific heat</td><td>Density</td><td>Electrical conductivity</td></tr><tr><td><i>k</i>(W/m⋅K)</td><td><i>c</i>(J/kg⋅K)</td><td><i>ρ</i>(kg/m<sup>3</sup>)</td><td><i>σ</i>(S/m)</td></tr><tr><td>Plastic</td><td>0.026</td><td>1... | <table><tr><td rowspan="2">Material</td><td>Thermal conductivity</td><td>Specific heat</td><td>Density</td><td>Electrical conductivity</td></tr><tr><td>k(W/m⋅K)</td><td>c(J/kg⋅K)</td><td>ρ(kg/m3)</td><td>σ(S/m)</td></tr><tr><td>Plastic</td><td>0.026</td><td>1045</td><td>70</td><td>10-5</td></tr></table> | <table><tr><td rowspan="2">Material</td><td>Thermal conductivity</td><td>Specific heat</td><td>Density</td><td>Electrical conductivity</td></tr><tr><td>k(W/m⋅K)</td><td>c(J/kg⋅K)</td><td>ρ(kg/m3)</td><td>σ(S/m)</td></tr><tr><td>Electrode</td><td>70</td><td>840</td><td>6450</td><td>108</td></tr><tr><td>Saline</td><td>0.... |
d02a0000a11b70f0c61e1864c1efd16228cfcc149abb0d8768c8c55bdcae8f95.png | simple | <table><tr><td></td><td>Beijing (<i>n</i> = 151)</td><td>Suzhou (<i>n</i> = 180)</td><td>Guangzhou (<i>n</i> = 178)</td><td><i>p</i>-Value <sup>1</sup></td><td><i>Post hoc</i> Test <sup>2</sup></td></tr><tr><td>B-carotene</td><td>1.7 (1.3–3.2)</td><td>2.4 (1.7–4.3)</td><td>2.7 (1.7–5.0)</td><td><0.... | <table><tr><td></td><td>Beijing (n = 151)</td><td>Suzhou (n = 180)</td><td>Guangzhou (n = 178)</td><td>p-Value 1</td><td>Post hoc Test 2</td></tr><tr><td>B-carotene</td><td>1.7 (1.3–3.2)</td><td>2.4 (1.7–4.3)</td><td>2.7 (1.7–5.0)</td><td><0.001 *</td><td>C1 < C2 = C3</td></tr><tr><td>β-cryptoxanthin</td><td>1.1 (0.8–2... | <table><tr><td>α-tocopherol</td><td>215 (117–333)</td><td>296 (208–478)</td><td>285 (148–479)</td><td><0.001 *</td><td>C1 < C2 = C3</td></tr><tr><td>γ-tocopherol</td><td>71 (48–107)</td><td>94 (59–148)</td><td>53 (31–88)</td><td><0.001 *</td><td>C3 < C1 < C2</td></tr></table> |
00ba3f200f40da2b9a24785051671b63ba0fe1b864891507b32723dfd434e6e8.png | complex | <table><tr><td></td><td>Stats</td><td>infAP</td><td>infNDCG</td><td>P@10 (+partial)</td><td>NDCG@10</td><td>P@10 (-partial)</td><td>UIR</td></tr><tr><td rowspan="2">SIB Text Mining</td><td>rank</td><td>1/10</td><td>5/10</td><td>5/10</td><td>3/10</td><td>2/10</td><td>2/10</td></tr><tr><td>score</td><td>0.3664</td><td>0.... | <table><tr><td></td><td>Stats</td><td>infAP</td><td>infNDCG</td><td>P@10 (+partial)</td><td>NDCG@10</td><td>P@10 (-partial)</td><td>UIR</td></tr><tr><td rowspan="2">SIB Text Mining</td><td>rank</td><td>1/10</td><td>5/10</td><td>5/10</td><td>3/10</td><td>2/10</td><td>2/10</td></tr><tr><td>score</td><td>0.3664</td><td>0.... | <table><tr><td></td><td>Stats</td><td>infAP</td><td>infNDCG</td><td>P@10 (+partial)</td><td>NDCG@10</td><td>P@10 (-partial)</td><td>UIR</td></tr><tr><td rowspan="4">All participants</td><td>min</td><td>0.0876</td><td>0.3580</td><td>0.5333</td><td>0.4265</td><td>0.1600</td><td>−1.00</td></tr><tr><td>1st quartile</td><td... |
e0cf862499cc941b9e9c315b2f9039e8dd3575a40576c00a07e2f6254f8add35.png | complex | <table><tr><td rowspan="2">Level</td><td colspan="2">Snail</td><td colspan="2">NF-κB</td></tr><tr><td>Mean (95% CI)</td><td>Median (95% CI)</td><td>Mean (95% CI)</td><td>Median (95% CI)</td></tr><tr><td>Low</td><td>38.36 (34.54–42.19)</td><td>39.0 (36.74–41.26)</td><td>37.96 (34.42–41.50)</td><td... | <table><tr><td rowspan="2">Level</td></tr><tr></tr><tr><td>Low</td></tr><tr><td>High</td></tr></table> | <table><tr><td colspan="2">Snail</td><td colspan="2">NF-κB</td></tr><tr><td>Mean (95% CI)</td><td>Median (95% CI)</td><td>Mean (95% CI)</td><td>Median (95% CI)</td></tr><tr><td>38.36 (34.54–42.19)</td><td>39.0 (36.74–41.26)</td><td>37.96 (34.42–41.50)</td><td>39.0 (37.04–40.96)</td></tr><tr><td>29.20 (25.76–32.64)</td>... |
e8e43385a9d4afe9c3c7527ecb09d8714b157f68d12918a70cd458602f9956b9.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Simple myopia</td><td><i>P</i> value</td><td colspan="2">Astigmatism</td><td><i>P</i> value</td><td rowspan="2">ANOVA (four groups)</td></tr><tr><td>MMC</td><td>No MMC</td><td>Paired <i>t</i>-test</td><td>MMC</td><td>No MMC</td><td>Paired <i>t</i>-test</td></tr><t... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Simple myopia</td><td>P value</td><td colspan="2">Astigmatism</td><td>P value</td><td rowspan="2">ANOVA (four groups)</td></tr><tr><td>MMC</td><td>No MMC</td><td>Paired t-test</td><td>MMC</td><td>No MMC</td><td>Paired t-test</td></tr><tr><td>UC</td><td>0 ±</td><td... | <table><tr><td>VA (in logMAR)</td><td> 0</td><td>.141</td><td>872</td><td>0.137</td><td>0 ± 0</td><td>.1872</td><td>.4624</td></tr><tr><td>BCVA (in logMAR)</td><td>0 ± 0</td><td>0.05 ± 0.070</td><td>P = 0.1631</td><td>0.04 ± 0.137</td><td>0 ± 0</td><td>P = 0.1703</td><td>0.5193</td></tr><tr><td>Refractive error</td><td... |
c63419962810183d48dcb76150fd12cfa6e193f3d690cee6a7172a5b44a1ae79.png | complex | <table><tr><td></td><td colspan="4">Mean genome size (1C; pg) </td></tr><tr><td></td><td>*R1</td><td>*R2</td><td>*R3</td><td>Mean ± SD</td></tr><tr><td><i>Lestrimellita</i> sp (diploid males)</td><td>0.460</td><td>0.465</td><td>0.465</td><td>0.463 ± 0.003</td></tr><tr><td><i>Lestrimellita</i> sp (females)</td... | <table><tr><td></td><td colspan="4">Mean genome size (1C; pg)</td></tr><tr><td></td><td>*R1</td><td>*R2</td><td>*R3</td><td>Mean ± SD</td></tr><tr><td>Lestrimellita sp (diploid males)</td><td>0.460</td><td>0.465</td><td>0.465</td><td>0.463 ± 0.003</td></tr></table> | <table><tr><td>Lestrimellita sp (females)</td><td>0.455</td><td>0.465</td><td>0.470</td><td>0.463 ± 0.008</td></tr></table> |
ad968d2cf0566e259bf56f266dcad914764666e23fed16c1fbeece0f4fbb5ddc.png | simple | <table><tr><td></td><td>E-KNG</td><td>Q-KNG</td><td>Q-TSR</td><td>E-TSR</td></tr><tr><td>Number of values</td><td>105</td><td>105</td><td>105</td><td>105</td></tr><tr><td>Minimum</td><td>-0.435</td><td>0.051</td><td>0.029</td><td>-0.009</td></tr><tr><td>25% Percentile</td><td>0.308</td><td>0.465</td><td>0.200</td><td>0... | <table><tr><td></td><td>E-KNG</td><td>Q-KNG</td><td>Q-TSR</td><td>E-TSR</td></tr><tr><td>Number of values</td><td>105</td><td>105</td><td>105</td><td>105</td></tr></table> | <table><tr><td>Minimum</td><td>-0.435</td><td>0.051</td><td>0.029</td><td>-0.009</td></tr><tr><td>25% Percentile</td><td>0.308</td><td>0.465</td><td>0.200</td><td>0.164</td></tr><tr><td>Median</td><td>0.971</td><td>1.181</td><td>0.968</td><td>0.796</td></tr><tr><td>75% Percentile</td><td>1.585</td><td>1.772</td><td>1.6... |
3660ce505b5eaed2da2c2a95bfd697f25e50ce950d5e8139524f19cd5a3e64c5.png | simple | <table><tr><td>Gestational age</td><td>n</td><td>Colonization with enterococci</td><td>Colonization with multidrug-resistant enterococci</td><td>% multidrug-resistant enterococci</td></tr><tr><td>All patients</td><td>274</td><td>63 (22.9%)</td><td>36 (13.1%)</td><td>57.1%</td></tr><tr><td>≥ 37 weeks of gestation<... | <table><tr><td>Gestational age</td><td>n</td><td>Colonization with enterococci</td><td>Colonization with multidrug-resistant enterococci</td><td>% multidrug-resistant enterococci</td></tr></table> | <table><tr><td>All patients</td><td>274</td><td>63 (22.9%)</td><td>36 (13.1%)</td><td>57.1%</td></tr><tr><td>≥ 37 weeks of gestation</td><td>117</td><td>24 (20.5%)</td><td>10 (8.5%)</td><td>41.7%</td></tr><tr><td>32 – 36 weeks of gestation</td><td>94</td><td>18 (19.1%)</td><td>7 (7.4%)</td><td>38.9%</td></tr><tr><td>< ... |
b2202a1185a1e04beec7a73900c190313aa4335d93a337ed7ba532224416cb0b.png | simple | <table><tr><td>Dimensions of KCSE scale</td><td>n</td><td>Score range</td><td>Mean (SD)</td><td>No of items</td><td>Cron-bach’s alpha</td><td>Item-total correlation r > 0.20</td><td>Inter-item correlations r > 0.20 & <i>r</i> < 0.70</td></tr><tr><td>Attitude</td><td>174</td><td>2.8–4</td><td>3.... | <table><tr><td>Dimensions of KCSE scale</td><td>n</td><td>Score range</td><td>Mean (SD)</td><td>No of items</td><td>Cron-bach’s alpha</td><td>Item-total correlation r > 0.20</td><td>Inter-item correlations r > 0.20 & r < 0.70</td></tr><tr><td>Attitude</td><td>174</td><td>2.8–4</td><td>3.6 (0.27)</td><td>9</td><td>0.63<... | <table><tr><td>Dynamic state</td><td>165</td><td>2.4–4</td><td>3.4 (0.40)</td><td>5</td><td>0.54</td><td>4/5, 80%</td><td>6/10, 60%</td></tr><tr><td>Knowledge</td><td>172</td><td>1–4</td><td>3.0 (0.59)</td><td>7</td><td>0.91</td><td>7/7, 100%</td><td>20/21, 95%</td></tr><tr><td>Skills</td><td>170</td><td>1.1–4</td><td>... |
fcc6003941e1cc3d49397b4d0b6323c956e32c5d7bf92a1eb642357980055d34.png | simple | <table><tr><td></td><td>1.5 T</td><td>3 T</td></tr><tr><td>Number</td><td>9</td><td>10</td></tr><tr><td>Male;Female</td><td>3:6</td><td>4:6</td></tr><tr><td>Age (years)</td><td>52 [45.5–61.5]</td><td>50 [45.25–53]</td></tr><tr><td>Body-mass Index (kg/m<sup>2</sup>)</td><td>22.9 [20.1–26.9]</td><td>25.... | <table><tr><td></td><td>1.5 T</td><td>3 T</td></tr><tr><td>Number</td><td>9</td><td>10</td></tr><tr><td>Male;Female</td><td>3:6</td><td>4:6</td></tr></table> | <table><tr><td></td><td>1.5 T</td><td>3 T</td></tr><tr><td>Age (years)</td><td>52 [45.5–61.5]</td><td>50 [45.25–53]</td></tr><tr><td>Body-mass Index (kg/m2)</td><td>22.9 [20.1–26.9]</td><td>25.9 [22.5–29.4]</td></tr><tr><td>Ejection Fraction (%)</td><td>63.6 ± 4.9</td><td>61.1 ± 4.1</td></tr></table> |
710239fabfc74540bff02b936d46ff8bbadebca06a9309fce8ec6067f0fe5e41.png | complex | <table><tr><td rowspan="2"> </td><td colspan="4">Grade 10</td><td colspan="4">Grade 11</td><td colspan="4">Grade 12</td><td colspan="4">TOTAL</td></tr><tr><td colspan="2">boys</td><td colspan="2">girls</td><td colspan="2">boys</td><td colspan="2">girls</td><td colspan="2">boys</td><td colspan="2">girls</td><td colspan=... | <table><tr><td rowspan="2"></td><td colspan="4">Grade 10</td><td>Grade 11</td></tr><tr><td colspan="2">boys</td><td colspan="2">girls</td><td>boys</td></tr><tr><td>Scale</td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>M</td></tr><tr><td>(1) AV</td><td>5.32</td><td>4.11</td><td>3.43</td><td>2.76</td><td>5.93</td></tr>... | <table><tr><td colspan="3">Grade 11</td><td colspan="4">Grade 12</td><td colspan="4">TOTAL</td></tr><tr><td>boys</td><td colspan="2">girls</td><td colspan="2">boys</td><td colspan="2">girls</td><td colspan="2">boys</td><td colspan="2">girls</td></tr><tr><td>SD</td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>M</td><td... |
e8e3a305b0193ff9041c26e65850ba2854faab964097d73684de20783e0f48d8.png | simple | <table><tr><td>Characteristic</td><td>Partial helmet law</td><td>Universal helmet law</td><td><i>P</i>-value*</td></tr><tr><td>Number of motorcycle operators</td><td><i>N</i> = 28,207</td><td><i>N</i> = 45,552</td><td></td></tr><tr><td>Helmet used</td><td>42 %</td><td>88 %</td><td><0.01</td></tr><tr><td>Age (Median)... | <table><tr><td>Characteristic</td><td>Partial helmet law</td><td>Universal helmet law</td><td>P-value*</td></tr><tr><td>Number of motorcycle operators</td><td>N = 28,207</td><td>N = 45,552</td><td></td></tr><tr><td>Helmet used</td><td>42 %</td><td>88 %</td><td><0.01</td></tr><tr><td>Age (Median)</td><td>37</td><td>36</... | <table><tr><td>Suspicion of alcohol or drugsa</td><td>9 %</td><td>5 %</td><td><0.01</td></tr><tr><td>Rural locationa</td><td>17 %</td><td>31 %</td><td><0.01</td></tr><tr><td>Poor Surface Conditions</td><td>6 %</td><td>7 %</td><td><0.01</td></tr><tr><td>Crash record linked to a medical record</td><td>55 %</td><td>58 %</... |
b1f4c8bf1f189cb69bb9d1915f1519e70efd5417fa2774d77b08580af392c44f.png | simple | <table><tr><td>Breach Code</td><td>Sprint ≤1400 m (<i>n</i>)</td><td>Mile 1406–1750 m (<i>n</i>)</td><td>Middle 1800–2400 m (<i>n</i>)</td><td>Total (<i>n</i>)</td></tr><tr><td>8</td><td>55</td><td>24</td><td>13</td><td>92 (23. 90%)</td></tr><tr><td>9</td><td>29</td><td>11</td><td>4</td><td>44 (11.43%... | <table><tr><td>Breach Code</td><td>Sprint ≤1400 m (n)</td><td>Mile 1406–1750 m (n)</td><td>Middle 1800–2400 m (n)</td><td>Total (n)</td></tr><tr><td>8</td><td>55</td><td>24</td><td>13</td><td>92 (23. 90%)</td></tr><tr><td>9</td><td>29</td><td>11</td><td>4</td><td>44 (11.43%)</td></tr></table> | <table><tr><td>16</td><td>33</td><td>10</td><td>11</td><td>54 (14.03%)</td></tr><tr><td>17</td><td>84</td><td>42</td><td>42</td><td>168 (43.64%)</td></tr><tr><td>Other</td><td>18</td><td>6</td><td>3</td><td>27 (7.01%)</td></tr><tr><td>Total</td><td>219 (56.88%)</td><td>93 (24.16%)</td><td>73 (18.96%)</td><td>385</td></... |
60490be02c5a2bc99c93cf253e995b2ac36880388c6e042b567ccbd52646fc90.png | simple | <table><tr><td>Reference</td><td>Basin</td><td>Number of sequences</td><td>Number of species</td><td>Intraspecific distance (%)</td><td>Intrageneric distance (%)</td></tr><tr><td>Pugedo et al., 2016</td><td>Jequitinhonha</td><td>260</td><td>52</td><td>0-11.43 (0.44)</td><td>1.09-21.55 (12.16)</td></tr><tr><td>Nasciment... | <table><tr><td>Reference</td><td>Basin</td><td>Number of sequences</td><td>Number of species</td><td>Intraspecific distance (%)</td><td>Intrageneric distance (%)</td></tr><tr><td>Pugedo et al., 2016</td><td>Jequitinhonha</td><td>260</td><td>52</td><td>0-11.43 (0.44)</td><td>1.09-21.55 (12.16)</td></tr><tr><td>Nasciment... | <table><tr><td>Reference</td><td>Basin</td><td>Number of sequences</td><td>Number of species</td><td>Intraspecific distance (%)</td><td>Intrageneric distance (%)</td></tr><tr><td>Benzaquem et al., 2015∗</td><td>Amazon</td><td>110</td><td>14</td><td>0-9.8 (2.8)</td><td>2.2-22.5 (19.0)</td></tr><tr><td>Gomes et al., 2015... |
cd94981821856a6c6f9ce0747f20fea14c079a2a53b8dad0b779d0e633883006.png | simple | <table><tr><td>Practitioners</td><td>Patients</td></tr><tr><td>1) Theoretical Stance</td><td>1) Reasons for Therapy</td></tr><tr><td>A) Integrity of Self</td><td>A) specific, individual reason based on symptoms, illness, or sense of dis-ease</td></tr><tr><td>B) Human Capacity for Embodiment</td><td>B) motivational driv... | <table><tr><td>Practitioners</td><td>Patients</td></tr><tr><td>1) Theoretical Stance</td><td>1) Reasons for Therapy</td></tr><tr><td>A) Integrity of Self</td><td>A) specific, individual reason based on symptoms, illness, or sense of dis-ease</td></tr><tr><td>B) Human Capacity for Embodiment</td><td>B) motivational driv... | <table><tr><td>Practitioners</td><td>Patients</td></tr><tr><td></td><td>b) Body Sensation</td></tr><tr><td>C) Noticing/Discriminating/Discerning</td><td>C) Engagement in</td></tr><tr><td></td><td>a) Self Regulation</td></tr><tr><td></td><td>b) Self Care</td></tr><tr><td>D) Goal of Practice: Integration of Mind, Body an... |
d97f884351bb432302ccb176e713ee57c506a2f5a078109c7bfe4a14b74a8c78.png | complex | <table><tr><td rowspan="3"></td><td colspan="4">ACS</td><td colspan="4">SAP</td></tr><tr><td colspan="2">MACE</td><td colspan="2">MI</td><td colspan="2">MACE</td><td colspan="2">MI</td></tr><tr><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td></tr><tr><td>VVV of DBP, mm Hg... | <table><tr><td rowspan="3"></td><td colspan="4">ACS</td><td colspan="4">SAP</td></tr><tr><td colspan="2">MACE</td><td colspan="2">MI</td><td colspan="2">MACE</td><td colspan="2">MI</td></tr><tr><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td></tr><tr><td>VVV of DBP, mm Hg... | <table><tr><td>Minimum DBP, mm Hg</td><td>66 ± 10</td><td>66 ± 8</td><td>65 ± 9</td><td>74 ± 4</td><td>66 ± 9</td><td>67 ± 6</td><td>66 ± 9</td><td>71 ± 6</td></tr></table> |
be45baaebb02113ddfd8b4c41d9f511f0647061bd585f6237a7db337152163f7.png | simple | <table><tr><td>Characteristics</td><td>No (%)</td></tr><tr><td><i><underline>Age (years)</underline></i></td><td></td></tr><tr><td>20–24</td><td>9 (27.3)</td></tr><tr><td>25–34</td><td>9 (27.3)</td></tr><tr><td>35–49</td><td>12 (36.3)</td></tr><tr><td>>50</td><td>3 (9.1)</td></tr><tr><td><i><underl... | <table><tr><td>Characteristics</td><td>No (%)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>20–24</td><td>9 (27.3)</td></tr><tr><td>25–34</td><td>9 (27.3)</td></tr><tr><td>35–49</td><td>12 (36.3)</td></tr><tr><td>>50</td><td>3 (9.1)</td></tr><tr><td>No. of years working as applicator</td><td></td></tr><tr><td>... | <table><tr><td>Characteristics</td><td>No (%)</td></tr><tr><td>6 to 9</td><td>4 (12.1)</td></tr><tr><td>10 to 20</td><td>10 (30.3)</td></tr><tr><td>>20</td><td>3 (9.1)</td></tr><tr><td>Protective measure in use</td><td></td></tr><tr><td>Boots</td><td>8 (24)</td></tr><tr><td>Apron</td><td>1 (3)</td></tr><tr><td>Mask</td... |
9ccee6a78d1344a5e6c2fe9885f2ce61ad72ac43702cc6256da1e402982559a8.png | simple | <table><tr><td>Compound name</td><td>Retention time (min)</td><td>Cells</td><td>Leaves</td><td>[M-H]<sup>−</sup></td><td>Diagnostic<i>m/z</i>ions</td></tr><tr><td><i>cis</i>-4-<i>p</i>CoQA (4)</td><td>7.35</td><td>✓</td><td>✓</td><td>337.0933</td><td>173</td></tr><tr><td><i>trans</i>-4- <i>p</i>CoQA... | <table><tr><td>Compound name</td><td>Retention time (min)</td><td>Cells</td><td>Leaves</td><td>[M-H]−</td><td>Diagnosticm/zions</td></tr><tr><td>cis-4-pCoQA (4)</td><td>7.35</td><td>✓</td><td>✓</td><td>337.0933</td><td>173</td></tr><tr><td>trans-4- pCoQA (1)</td><td>7.96</td><td>✓</td><td>✓</td><td>337.0957</td><td>173... | <table><tr><td>trans-4-CQA (7)</td><td>6.13</td><td>✓</td><td>✓</td><td>353.0864</td><td>191, 179, 173, 135</td></tr><tr><td>trans-5-CQA (8)</td><td>5.81</td><td>✓</td><td>✓</td><td>353.0829</td><td>191, 135</td></tr><tr><td>cis-5-CQA (9)</td><td>7.55</td><td>✓</td><td>✓</td><td>353.0809</td><td>191, 135</td></tr><tr><... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.